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1. Introduction 
 
Biological activity, such as bacterial or viral infection, leaves behind measurable traces of 
its existence. These traces are commonly referred to as “biomarkers”, and they can be used 
in the detection or monitoring of the medical conditions they are related to.1 Biomarkers can 
be, for example, the byproduct of a diseased organ or bacteria infecting a host, or they can 
be purposely supplied to the human body as labeled molecules. Biomarkers are numerous, 
and their features vary greatly – some are enormous macromolecules, such as proteins, and 
others are comprised of only a few atoms. The water and fat solubility of biomarkers also 
vary greatly, and some biomarkers are able to easily change phase from liquid to gas, and 
are therefore referred to as “volatile”. Most biomarkers are commonly identified with 
traditional analysis techniques, such as blood or urine tests, however, in the last few decades 
the analysis of volatile biomarkers from gas samples has been the target of increased interest. 
Especially exhaled breath analysis has been considered an attractive alternative for the 
traditional analysis techniques, which are invasive, and their samples generally laborious to 
take. Breath analysis, on the other hand, provides a noninvasive and quick means to analyze 
a gaseous sample, which has practically limitless volume, and is easy to take, even by the 
patients themselves.2 Breath analysis is already used routinely in the diagnostics of certain 
medical conditions, such as asthma3 and Helicobacter pylori infection,4 however, there are 
several other conditions that could also be analyzed with the help of breath testing. The first 
part of this thesis concentrates on the analysis of volatile, small-molecule biomarkers, 
introducing a few of them in detail, including the medical conditions they are related to, as 
well as the advantages and challenges concerning their analysis. The biomarkers discussed 
in this thesis are hydrogen cyanide (HCN), ammonia (NH3), nitric oxide (NO), hydrogen 
sulfide (H2S), acetone (C3H6O) and methane (CH4). 
The second part of this thesis introduces a laser based, cavity-enhanced absorption technique 
that can be used to measure volatile, small-molecule biomarkers, such as those mentioned 
above. The measurement technique in question is cavity ring-down spectroscopy (CRDS). 
Its main features, as well as its advantages and limitations especially considering breath 
analysis, are discussed in detail. Other relevant analysis techniques, such as mass 
spectrometry (MS) and sensors, are also briefly introduced, and their features compared to 
those of CRDS. Measurement of volatiles, especially the sampling of bacterial headspace 
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and breath gas, is discussed thoroughly. Special emphasis is given to the custom built 
sampling line constructed in our laboratory, and it is used as a descriptive example, when 
discussing the handling of gaseous samples. The measurement setups used in the 
experimental part of this thesis, and developed in our laboratory for the headspace 
measurements of both aerobic and anaerobic bacteria, are also introduced in more detail. 
The third part of this thesis describes the bacterial headspace measurements done with the 
custom built CRDS instrument and sampling setup of our laboratory. The aim of this 
experimental demonstration was to investigate, whether some oral bacteria are able to 
produce detectable amounts of HCN in vitro, identify these bacteria, and monitor their HCN 
production as thoroughly as possible. Oral bacteria capable of producing HCN could 
possibly affect the concentrations measured from human exhaled breath, and therefore this 
should be taken into account in the HCN breath analysis. In the future, HCN could also be 
considered a possible biomarker for oral pathogenic bacteria responsible for periodontal 
diseases, if these bacteria produce HCN in detectable amounts. Another aim of this 
experimental demonstration was to prove that our suggested measurement setup is suitable 
for both anaerobic and aerobic bacterial headspace measurement, and that it offers reliable, 
consistent and reproducible results. The methods and results of the experimental 
demonstration are described and discussed thoroughly in this thesis, as well as in our 
published paper.5 
The last part of this thesis focuses mainly on the future diagnostic prospects of volatile, 
small-molecule biomarkers, with special emphasis on breath analysis and bacterial 
measurements. Research concerning analysis of volatiles, finding new biomarkers and 
improving the usage of old ones, is essential in the future of better, faster, easier and cheaper 
health care. Many of the small-molecule biomarkers discussed in this thesis are connected 
to medical conditions, such as diabetes and heart failure, which affect the health of millions 
of people around the world, and have a major impact on the global economy. Therefore, it 
is important to acknowledge the possibilities in the analysis of such biomarkers, as well as 
finding out how they could increase both the quality and availability of healthcare, and at 
the same time, decrease its cost. These themes are discussed in the last part of this thesis, 
which ultimately aims to establish that with co-operation of basic and applied research in the 
fields of chemistry, biology, medicine, engineering, and many others, it is possible to 
improve our knowledge of diseases and their treatment, and offer better healthcare and 
quality of life for increasingly larger portion of the human population. 
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2. Biomarkers 
 
Biomarkers are indicators of biological activity, a state or a condition, and they are detected, 
measured and analyzed during the diagnostics of the conditions they are related to. 
Biological activity leaves traces of itself into the environment it exists in, and these 
measurable traces, such as DNA or metabolic byproducts, are known as biomarkers.1 
Biomarker analysis is connected to various fields of scientific research, the most 
distinguished of which is the medical field. In medicine, biomarkers are indicators of the 
presence, or the degree of a disease or a physiological condition.4 These biomarkers can be 
released, for example, by invading bacteria or a diseased organ, or they can be introduced 
into the human body artificially, as is done in isotopic labeling. Biomarkers are numerous, 
as are the conditions they are related to. In addition, some biomarkers can be connected to 
multiple conditions, and some conditions can have multiple biomarkers. This thesis 
concentrates on small and volatile biomarkers, which can be measured with laser based 
techniques, such as the one used in the experimental part. These small-molecule volatiles, 
their connection to certain diseases and medical conditions, and their roles as possible 
biomarkers are discussed in the following chapters. 
 
2.1 Volatile Biomarkers 
 
Biomarkers are traditionally measured from the blood, where they are released to by the 
metabolism of various cells, which can be either from the organism itself, or from an 
intruder. Biomarkers can be divided into different groups according to their physical and 
chemical properties, such as solubility or volatility.6 Volatility of a biomarker means its 
tendency to vaporize, or in other words, change phase from liquid to gas, and is therefore, 
directly dependent on the vapor pressure of the substance. At a given temperature, substances 
with higher vapor pressure have higher tendency to evaporate compared to substances with 
lower vapor pressure. Consequently, in normal temperatures, such as the temperature of the 
human body, substances with high vapor pressure are referred to as volatile. 
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The number of volatile biomarkers is enormous. They include both volatile organic 
compounds (VOCs), such as acetaldehyde and acetone, and volatile inorganic compounds, 
such as HCN and NH3. After being released to our blood stream by different cells, these 
compounds are transferred by circulating blood to multiple different locations in our bodies, 
for example, to kidneys and lungs. Different organs further transfer these biomarkers into 
different secretion media, such as urine, breath or saliva, and secrete them out of the body. 
These secretion media can be collected and the volatile biomarkers analyzed, for example, 
from the gas above the liquid phase (headspace) of urine7 or saliva, or from an exhaled breath 
sample.8 
This thesis focuses on volatile biomarkers, with a special interest on those suitable for breath 
analysis. A few important examples of these volatile biomarkers, and their connection to 
different pathogens and medical conditions, are discussed in section 2.2. Breath analysis as 
a diagnostic tool is introduced in this section, including discussion on its advantages and 
limitations, and applicability in clinical work. The aim of this section is to show, why in 
some cases the breath analysis of volatile biomarkers is a good alternative for traditional 
analysis methods, and how breath analysis could be further integrated into the clinical 
environment as a diagnostic tool. 
 
2.1.1 Respiratory System and Gas Exchange 
 
The human respiratory system consists of upper airways – the nasal and oral cavities, 
pharynx and larynx – and lower airways – trachea, bronchi, bronchioles and pulmonary 
alveoli. Bronchioles and alveoli are located in the left and right lung. A muscle called 
diaphragm controls the physical action of breathing by contracting and relaxing, and thus 
changing the volume of the chest cavity, which allows air to flow into or out of the lungs. 
The main purpose of breathing, also referred to as respiration or ventilation, is to bring 
oxygen into the body, and remove carbon dioxide (CO2) from it. Oxygen is needed in the 
cellular respiration – a set of metabolic reactions, where biochemical energy from consumed 
nutrients is converted into more compact form, easily accessible and more suitable for cells 
to use. Carbon dioxide, on the other hand, is released by cells as a metabolic waste product 
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of the cellular respiration processes. Because it is toxic for cells, it has to be ultimately 
removed from the body.  
The inhaled air consists mostly of oxygen, nitrogen and argon, which are the most prominent 
components of the Earth’s atmosphere. Other gasses are also present, and their 
concentrations depend on the composition and quality of the local ambient air. Exhaled air, 
on the other hand, consists mostly of CO2, oxygen, nitrogen, argon and water, as well as 
small amounts of other volatile substances9 transferred through the body to lungs by 
bloodstream. These trace amounts of other substances can originate from endogenous or 
exogenous sources.6 Endogenous sources are within the body, and include the metabolism 
of different cells, from where they are released to the bloodstream, and carried out of the 
body. Exogenous sources, on the other, are outside the body, and include the food and drink 
consumed and air breathed. Exogenous substances enter the body from external sources, and 
are transferred through the body by blood, which eventually carries them to organs 
responsible for the removal. By monitoring the endogenous substances, information can be 
gained about the internal condition of the body, for example about the health of an organ, 
whereas monitoring the exogenous substances gives information about the external 
conditions, for example about exposure to pollutants.  
The ventilation process has multiple phases. With inhalation, ambient air flows through the 
upper and lower airways into the lungs – a process during which the air mixes, warms and 
moistens. In the lungs, a gas exchange between alveoli and blood takes place, after which 
blood circulates to tissues, and another gas exchange happens between blood and cells. This 
process repeats itself in the other direction, and ultimately exhalation takes place. Figure 1 
illustrates the structure of pulmonary alveoli, and the process of gas exchange in a simplistic 
way. Alveolar air is in equilibrium with blood, and consequently, the concentrations of 
volatile compounds in blood are reflected by their concentrations in the alveolar air. The part 
of exhaled breath, which best resembles the alveolar air composition, and thus blood 
composition, is the last fraction, known as “end expired air” or “end-tidal air”.10 It is not, 
however, completely identical to alveolar air in most cases. At the present, breath analysis 
in diagnostics relies heavily on end-tidal sampling, and it has been reported that the 
consistency and reproducibility of the results are better, when only the end-tidal fraction of 
the exhaled breath is used.11 The term “dead space” is generally used for the fraction of 
exhaled air, which does not reach the alveoli, and is therefore not in equilibrium with blood. 
Dead space consists of the air from upper airways and bronchi. 
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Fig.1. Representation describing the position of alveoli in the respiratory system (on the 
left), and their simplified structure and gas exchange with blood vessels (on the right).12 
Gas exchange between air and blood happens mostly through convection and diffusion, and 
its effectiveness is dependent on ventilation and pulmonary perfusion, as well as the 
solubility, reactivity and blood-gas partition coefficient of the transferred substance.13 
Convection is a transfer process happening through a flux caused by temperature differences. 
Temperature differences induce density gradients inside the gaseous or liquid matter, and 
consequently, the less dense warmer matter rises above the cooler and denser one, generating 
a flux in that direction. Convection can also be induced by external hydrostatic pressure. 
Diffusion, on the other hand, is a transfer process, where matter moves from the environment 
of larger concentration towards the environment of smaller concentration. Diffusion through 
tissues is dependent on the polarity, size and charge of the substance, as well as its solubility 
in water or fat.14 
Blood consists of different blood cells and plasma. Plasma is mainly water, and constitutes 
about 55% of blood. Water soluble substances dissolve in the water contained by blood, and 
are therefore, transferred to tissues in dissolved form. Substances that are insoluble in water, 
however, bind to other components of blood, such as the blood cells or proteins. For 
example, oxygen binds to the hemoglobin in the red blood cells, and is transferred to tissues 
by them, because it dissolves poorly in water. Water solubility of substances also defines the 
area of the airways, in which the gas exchange takes place.13 Water insoluble substances 
transfer to blood mainly in the alveoli, but water soluble substances can transfer already in 
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the trachea or bronchi. This, of course, affects the concentrations of substances present in 
exhaled and inhaled breath, and has to be taken into account in breath analysis. Some 
substances, like polar acetone, can also react with the mucosal lining of the airways, which 
can affect the concentrations observed in breath as well.14 Effectiveness of the pulmonary 
gas exchange is also dependent on the rate of breathing, volume of the lungs and the 
performance of the cardiovascular system.15 These features, on the other hand, are dependent 
for example on the age, gender, physical condition and overall health of an individual, which 
need to be taken into account, when developing a breath analysis technique.9 
 
2.1.2 Main Features and Advantages of Breath Analysis 
 
Modern breath analysis has its origin in the 1970s, when Linus Pauling and his colleagues 
identified quantitatively over 200 different substances from the human exhaled breath and 
urine headspace, by gas and liquid chromatography.7 Nowadays, breath analysis is used, 
when identifying the alcoholic content of a person’s blood, in various exposure tests, and in 
the diagnostics of certain diseases. Measurements of the gasses emitted from the skin of a 
person can also be considered a form of breath analysis,16 but this is not discussed further in 
this thesis. 
Breath samples can be collected in various ways depending on the measured substance, as 
well as the measurement instrument available.9 As mentioned earlier, especially the water 
solubility of the substance affects the method, by which the sample is taken. Breath sample 
can be exhaled straight into the analyzer, or it can be collected, for example, into a sample 
bag or a container. Sampling and instrumentation in breath analysis are discussed more 
thoroughly in chapter 3. 
Breath analysis has many advantages compared to the traditional methods, such as blood 
and urine analysis.2,9,10,15,17 First of all, the sampling in breath analysis is noninvasive, 
whereas blood and urine tests, or a bronchoscopy, can be extremely unpleasant and painful 
to many people – especially children. Elderly people with fragile veins can also benefit 
greatly from a noninvasive method, as well as individuals, such as diabetics, who must take 
blood samples daily. Another great advantage of breath analysis is the sample medium itself. 
The collectable volume of exhaled breath is practically limitless, whereas, for example, 
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blood and urine can only be collected from one person a limited number of times per day. 
Breath samples can be collected as often as is required, and consequently, diurnal changes 
in biomarker concentrations can be recorded, which is not easily achieved with traditional 
methods. Continuous sampling of breath is also possible, which allows the easy monitoring 
of breath constitution in real-time.  
Blood, urine and biopsy analysis require time, because after collection the samples are 
generally sent to the laboratory for further analysis. However, with breath analysis the results 
can be gained immediately after sampling, because with certain measurement techniques the 
method requires no additional laboratory work or specific expertise. The easiness and 
swiftness of breath analysis also saves valuable time and resources from both the healthcare 
personnel, as well as the patient. In some cases, the breath samples can even be collected at 
home by the patients themselves, which further decreases the amount of time spent in 
hospitals, as well as the cost of the treatment. In addition, breath analyzers can already be 
made into a portable or handheld size, so they fit well in smaller clinics and hospitals, as 
well as larger ones. The portability also makes them suitable for field work, and 
consequently, they can be stationed in ambulances or fire trucks, if needed.   
 
2.1.3 Applicability of Breath Analysis in Diagnostics 
 
Breath analysis has been a part of diagnostics for a number of years now. Most common 
examples of standardized breath testing are instruments that measure the blood alcohol 
content from a breath sample – commonly referred to as “breathalyzers”. These instruments 
are routinely used, for example, by the law enforcement to estimate the level of intoxication 
of a person, and consequently, their capability to control a vehicle. Breath tests also routinely 
used in health care are the urea and NO breath tests. Of these two, the urea breath test is 
nowadays the recommended diagnostic tool for the detection of H. pylori infection.18 In this 
test, the patient ingests carbon-13 or carbon-14 labeled urea, and if H. pylori is present in 
the stomach of the patient, the bacteria will break down the supplied urea into ammonia and 
isotope labeled CO2. This isotope labeled CO2 can be detected from the exhaled breath, and 
H. pylori infection consequently identified. The breath test for H. pylori is considered easier, 
quicker and cheaper than, for example, the stool test. It is also less invasive than a biopsy 
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taken during an endoscopy.18 The blood test for H. pylori, on the other hand, can give a false 
positive result, because the antibodies related to the infection can stay in the blood for a long 
time after the bacterial infection is gone. Urea breath test is also more accurate (>95%) than 
stool (91-93%) and blood (80-84%) tests.19 The other routinely used breath test mentioned 
above, the NO test, is mainly used in the identification of asthma,3 but has also been 
connected to other conditions characterized by the inflammation of the airways.20 NO as a 
biomarker is discussed more thoroughly in section 2.2.  
In addition to the standardized breath tests mentioned above, a number of other tests have 
also been included in the clinical practice of some countries. For example, the hydrogen 
breath test (HBT), which measures the amount of hydrogen present in the exhaled breath, is 
commonly used for the detection of small intestine bacterial overgrowth (SIBO) and 
carbohydrate malabsorption.21 However, as SIBO and related conditions are still poorly 
understood and the accuracy of HBT is not ideal, it will take time for HBT to reach a similar 
place in routine diagnostics as the tests for asthma and H. pylori.      
Breath tests for various cancers, such as lung and breast cancer, are in development, as are 
tests for food allergies and pulmonary tuberculosis (TB).9 Some of these tests are already 
going through Phase II or Phase III of the clinical studies, which evaluate the safety, 
effectivity and applicability of suggested tests in clinical diagnostics.  Potential of breath 
analysis in the diagnostics of liver diseases has also been studied. Proposed biomarkers for 
liver cancer are sulfur compounds,9,22 including dimethyl sulfide and hydrogen sulfide, and 
proposed biomarkers for liver failure, cirrhosis and severe hepatitis are NH3 and certain 
VOCs, such as acetone.23,24 Diabetes mellitus has also been considered as a potential medical 
condition for breath analysis. Exhaled breath of diabetics sometimes smells sweet, and this 
odor is nowadays known to originate from acetone, which is produced excessively by the 
liver of diabetic patients. Elevated acetone levels in exhaled breath have, therefore, been 
suggested as a sign of diabetes. However, both liver diseases and diabetes mellitus have 
proven to be challenging for breath analysis, mainly because of the metabolism of the 
biomarkers mentioned above, and their exact connection to the proposed diseases, are still 
poorly understood.9 Section 2.2 discusses NH3, H2S and acetone as biomarkers in more 
detail. 
Standardization is the main issue concerning breath analysis,15 and it makes the introduction 
of new breath tests into clinical practice challenging. In many cases, the distinction between 
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healthy subjects and patients has been difficult to make, because concentrations of measured 
biomarkers have been unexpected or controversial between the two groups. Therefore, some 
guidelines of normal ranges, as well as minimum limits indicative of disease, should be 
established in the future, in order for new breath analysis techniques to be applicable in 
clinical diagnostics. This has already proven to be difficult, however, because the 
relationship between diseases and the metabolic pathways, and thus biomarker generation, 
is still poorly understood in many cases.25 Variables, such as age, gender, and physical 
condition add even more challenges to the standardization of breath tests. Other aspects that 
should be addressed are: distinguishing between endogenous and exogenous substances, 
actual origin of the measured biomarker, generation of biomarkers in the oral cavity by 
microbes, the potential of nose exhaled breath, thorough understanding of pulmonary gas 
exchange, and standardized sampling.9,15 In addition, for a breath test to be applicable in 
clinical work, it must be sufficiently accurate, quick and cheap compared to the already 
existing analysis method. As mentioned earlier, breath analysis has immense potential as a 
diagnostic tool, but the inconsistency of research and lack of standardization is hindering its 
progress. In the future, special attentions should be given at least to the aspects mentioned 
above, and the quality of breath analysis research increased even further.   
 
2.2 Small-Molecule Biomarkers 
 
In this thesis, the term “small-molecule” refers to molecules that consist of only a few atoms, 
and are therefore sufficiently easy to measure with laser-based absorption spectroscopy 
(LAS), which is utilized in the experimental part of the thesis. Large molecules produce 
absorption spectra with multiple overlapping of signals, which makes the spectra difficult to 
interpret. Consequently, large molecules, such as most VOCs, are rarely studied with 
absorption spectroscopy, but rather with different MS techniques or sensors. In contrast, 
small molecules produce clear spectra, with significantly less overlapping, and can therefore, 
be effectively measured with absorption spectroscopy. The applicability of CRDS in the 
analysis of small-molecule volatiles, as well as its comparability to MS and other relevant 
techniques, is discussed more thoroughly in chapter 3. 
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Small-molecule biomarkers introduced and discussed in this section are HCN, NH3, NO, 
H2S, acetone and methane. These molecules were chosen to emphasize the large variety of 
medical conditions small-molecule biomarkers are connected to. The aim of this section is 
to introduce and review why these molecules can be found in the human body, and what 
their existence implies. 
 
2.2.1 Hydrogen Cyanide 
 
HCN is commonly known for its poisonous uses in murders, suicides and chemical warfare, 
and especially as Zyklon B in the extermination camps of World War II. However, HCN also 
occurs naturally in the human body, and in small amounts it has no lethal effects. HCN is 
naturally produced, for example, by certain neutrophils during phagocytosis.26 HCN is also 
produced in many plants, and it is a component of tobacco smoke and car exhaust. Some 
microbes can also produce HCN,27-29 and therefore, it is a possible biomarker for certain 
infections. 
As mentioned, human body has a natural background level of HCN, which originates 
endogenously as a metabolic product of different cells, or exogenously from the air inhaled 
or food consumed. However, sometimes the amount of HCN can increase above the natural 
level, for example, as a result of a bacterial infection. Many HCN producing bacteria are 
already known, for example, cyanobacteria Anacystis nidulans and Nostoc muscorum, 
rhizobacteria Rhizobium leguminosarum and Solanum tuberosum, and proteobacteria 
Pseudomonas aeruginosa, Pseudomonas aureofaciens and Pseudomonas fluorescens.27-29 
However, most of them are not human pathogens and are instead connected to plant, soil and 
water systems. P. aeruginosa is the most well-known HCN producing human pathogenic 
bacteria, and it can produce significant amounts of HCN from glycine through enzymatic 
decarboxylation.30 The enzyme related to this process is HCN synthase, controlled by an 
hcnABC gene cluster.28,31 However, in our study, we have found that other human pathogenic 
bacteria can also produce HCN,5 even though this has not been reported earlier. The 
mechanisms of HCN production by these bacteria are still unknown, but they are most likely 
similar to that of P. aeruginosa and other known cyanogenic bacteria. It should be noted that 
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HCN is generally a secondary metabolite,30 meaning that it is not a main product of bacterial 
metabolic reactions. 
HCN production is not common among prokaryotes. It has previously been assumed that it 
can be produced only by a few human pathogenic proteobacteria, including P. aeruginosa. 
This bacterial species is extremely versatile and adaptive – it can survive with various kinds 
of nutrients, as well as in aerobic, micro-aerobic or anaerobic conditions. It is known to infect 
patients with various external traumas or reduced immunity, and the infection can be fatal, 
when targeting vital internal organs, such as the kidneys or the lungs. High-risk groups for 
P. aeruginosa infection are cystic fibrosis (CF) patients, patients with infected wounds or a 
decreased number of neutrophils, burn victims and prematurely born infants. However, P. 
aeruginosa infection is most common among patients with CF, which is a genetic, autosomal 
and recessively heritable disorder, where the lungs, respiratory track and sinuses are 
frequently under infections. Symptoms include coughing, difficulty in breathing, poor 
growth, and the development of thick mucus in the respiratory track. This mucus blocks the 
airways, and results in inflammation caused by bacteria, which can ultimately lead to 
pneumonia. In additions, structural changes in the lungs and respiratory track makes 
breathing increasingly difficult, which can cause hypoxia, elevated blood pressure, 
respiratory failure, hemoptysis and even heart failure. P. aeruginosa has been identified as 
the leading cause of morbidity and mortality in CF patients, and it is especially dangerous to 
infants and children.32 The HCN produced by P. aeruginosa has been linked to its potent 
virulence in CF patients. Bacteria isolated straight from the CF lung were found to have 
significantly elevated expression of the hcnABC gene, compared to bacteria grown in vitro.33 
The observed HCN concentrations measured from the nose-exhaled breath of adults with P. 
aeruginosa infection, were ten times higher than those of healthy individuals.34 In another 
study, the HCN levels of the mouth-exhaled breath from CF children, were also significantly 
elevated.35 These results suggest that HCN is a specific biomarker for P. aeruginosa 
infection, however, more basic and clinical research is needed, in order to develop a reliable 
and standardized breath test.    
Gram-negative bacteria have been acknowledged as major contributors in the development 
of destructive periodontal diseases, which cause chronic inflammation in the oral cavity, 
ultimately leading to erosion of the connective tissue around teeth. Untreated, inflammation 
and destruction of both the soft tissue and bone, can cause tooth loss and irreversible changes 
in the structure of the oral cavity. The oral cavity and the microenvironment of the 
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periodontal pockets have diverse bacterial flora, however, only some of the existing species 
have been connected to diseases and are referred to as “periodontal pathogens”. Amongst 
these bacteria, three species seem to contribute most significantly to the development of 
aggressive periodontal diseases – P. gingivalis, Actinobacillus actinomycetemcomitans and 
Tannerella forsythia.36 According to a survey done by the Finnish National Public Health 
Institute 74% of the 5255 adult subjects had some inflammation of the gum tissue,37 known 
as gingivitis. Untreated, this nondestructive periodontal disease can progress into 
periodontitis, which is a destructive disease. According to the same survey, 64% of subjects 
had deepened gum pockets, and 21% had already developed periodontitis of some stage. 
This study suggests that periodontal diseases affect a major part of the adult population, and 
are often underdiagnosed. Early diagnosis can drastically decrease the probability of 
gingivitis developing into periodontitis, and consequently, reduce the cost and time required 
by the treatment. HCN production of oral bacteria has been unknown until recently, 
however, the research done for this thesis proves that oral anaerobes are capable of HCN 
production in vitro. According to these results, HCN could be a possible biomarker for oral 
pathogenic bacteria, if they are also able to produce HCN in vivo.  
Increased amount of HCN in the exhaled breath can also have exogenous origins. These 
include plants that contain an enzyme called beta-glucosidase, which catalyzes the 
hydrolysis of glycosidic bonds, and consequently, releases cyanide from soluble glucosides 
– amygdalin and prunasin. Seeds of certain plants, such as apple, plum, peach, apricot and 
bitter almond, are rich in these cyanogenic glucosides, and consuming the seeds of these 
plants can result in an increased concentration of HCN in the blood and exhaled breath. 
Cassava root, which is an important source of nutrients in the tropical countries, also contains 
cyanogenic glucosides. Inhaled air is another exogenous source of HCN. Ambient air usually 
contains some trace amounts of HCN, but these normal levels can increase significantly, for 
example, as a result of a fire. The burning of wood and items, such as furniture and 
electronics containing plastics or paints, release significant amounts of HCN, which can be 
a serious hazard for fire victims. HCN poisoning is a life-threatening condition, which occurs 
when a person inhales air, with sufficiently large amounts of HCN for a long enough period 
of time, and the concentration of HCN in the body increases to a lethal level. Exhaust fumes 
from vehicles and factories also contain HCN, as does tobacco smoke. They are difficult to 
avoid, especially in larger cities, and inhaling the smokes or the fumes can increase the level 
of HCN in the body and exhaled breath. 
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The main challenge in the HCN breath analysis is the distinction between normal levels in 
healthy subjects, and abnormal levels in patients or affected individuals. Many studies have 
been made in order to identify the range for normal levels of HCN,8, 38-40 but no consensus 
has been reached yet. One of the problems seems to be the surprisingly high levels of exhaled 
HCN in healthy individuals – a subject, which is further discussed in the experimental part 
of this thesis. Nonetheless, HCN is a specific biomarker at least for P. aeruginosa infection, 
and could become a leading diagnostic tool for CF, if the challenges considering HCN breath 
analysis are overcome through future research in this area. Breath analysis could also prove 
to be useful in the diagnostics of HCN poisoning, which is the other major complication in 
fire victims along with carbon monoxide poisoning. These conditions cause similar 
symptoms, and are difficult to distinguish from each other, however, the treatment for them 
is vastly different. Therefore, a tool that could recognize HCN poisoning would be valuable, 
and portable analyzers in ambulances or fire trucks could save valuable time, as well as 
decrease the number of misdiagnoses in the field, where resources are limited.      
 
2.2.2 Ammonia 
 
NH3 is one of the most important components of the nitrogen cycle of the human metabolism. 
It enters our bodies through the amino acids of proteins in the food and drink we consume. 
Most amino acids are processed in the liver, where amino groups are separated from the 
other components, and either recycled to be reused by the cells, or converted into urea and 
secreted into the bloodstream. Urea, which is far less toxic for the human body than NH3, is 
transferred to the kidneys by blood, and kidneys secret it further into urine and out of the 
body.  
Liver and kidneys are in a crucial role considering the NH3 and nitrogen cycle of the human 
body. Inefficient or defective function of either of them can cause the increase in NH3 level 
of blood, which in turn can lead to serious or even fatal medical conditions. The unnaturally 
high NH3 concentration of blood is referred to as “hyperammonemia”, and it can lead to fatal 
conditions, such as brain dysfunctions. High urea concentrations, on the other hand, can lead 
to the over secretion of interstitial fluid, tissue edema and the acidification of plasma, and is 
usually the result of problems in the kidney function. Monitoring changes in the NH3 and 
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urea concentrations is therefore an excellent way to monitor liver and kidney functions, and 
NH3 as a volatile is a possible breath biomarker. 
In addition to several kidney and liver diseases, such as renal failure41 and cirrhosis,42 breath 
NH3 has also been proposed as a biomarker for monitoring the effectiveness of 
hemodialysis.43-45 In hemodialysis, the blood of patients with kidney dysfunction or failure 
is mechanically purified from metabolic waste products and excess water by a dialysis 
machine, because the kidneys of the patients are no longer able to do it naturally. NH3 could 
also be used as a biomarker for the bacterial infection caused by H. pylori,46 which was 
already briefly mentioned in the earlier sections. H. pylori infection exposes carriers to 
gastritis, stomach and duodenal ulcers, gastrointestinal cancers and arthritis. H. pylori 
produces urease enzyme, which breaks urea down into NH3 and CO2, thus increasing the 
levels of these substances in the blood and exhaled breath. As mentioned earlier, CO2 is 
already used routinely in the diagnosis of H. pylori infection, however, NH3 could also have 
some potential in that field. Even though NH3 has been proposed as a breath biomarker 
especially for various kidney and liver diseases, a conclusion about the usage of exhaled 
NH3 in diagnostics has not been reached. In most studies, reliable correlation between NH3 
and proposed disease has not been found, and it also seems that a significant portion of NH3 
is produced in the oral cavity, which makes the mouth exhaled breath analysis even more 
challenging. NH3 is one of the major components of mouth exhaled breath, with a mean 
concentration of 833 parts per billion (ppb), followed by acetone (477 ppb), methanol (461 
ppb), ethanol (112 ppb), isoprene (106 ppb), propanol (18 ppb), and acetaldehyde (22 ppb).9 
The concentrations of NH3 in the mouth exhaled breath are usually many times larger than 
the concentrations in nose exhaled breath.16, 47-49 These differences are thought to be caused 
by the diverse bacterial flora of the oral cavity capable of producing NH3,
50 for example, 
from the salivary urea. The inconsistencies in the NH3 levels of the mouth exhaled breath 
are problematic considering its usage as a biomarker, because the NH3 measured from the 
mouth exhaled breath does not necessarily reflect its concentration in blood. However, these 
difficulties could be solved, for example, by trying to minimize the activity of oral bacteria, 
or using alternative sampling methods, such as nose exhaled breath. Consequently, more 
research is needed to unravel the underlying correlation between NH3 and the proposed 
diseases, and to standardize both the mouth and nose exhaled breath tests to a reliable level.     
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2.2.3 Nitric Oxide 
 
Endogenous NO is one of the major components in the regulation of airway functions, and 
it has been connected to the inflammatory response of certain cells. In the human body, NO 
is produced from an amino acid called L-arginine, by the isoforms of an enzyme called NO 
synthase (NOS). These isoforms include two constitutive NO synthases called endothelial 
and neuronal NO synthases (eNOS, nNOS), which are connected to the regulation of the 
airways, and an inducible NO synthase (iNOS), which is connected to the inflammatory 
diseases in the airways, as well as infection response. The first two isoforms are constantly 
active in endothelial cells, which cover the interior surface of blood vessels and lymphatic 
vessels, and neurons, which process and transmit electro-chemical signals. The iNOS, on the 
other hand, is activated during inflammation, and many cells use it to produce NO in 
response to an inflammatory state. Extensive research on this area indicates that iNOS is the 
main contributor to NO in the human body during inflammation, and when active, it 
produces over 100 times more NO than either eNOS or nNOS.51         
Exhaled nitric oxide (eNO) levels are known to be increased in both adult52 and childhood53 
asthmatics. It has also been shown that the eNO levels decrease, when patients with asthma 
are treated with appropriate medication, suggesting that NO is indeed a suitable biomarker 
for asthma. Consequently, eNO offers valuable information regarding the nature of the 
underlying airway inflammation, and complements the diagnosis based on clinical 
symptoms,53 both of which have secured it a place in routine diagnostics. Chronic obstructive 
pulmonary disease (COPD), pulmonary hypertension and CF are other conditions connected 
to the increased levels of NO in the exhaled breath.54 Especially in patients with greater 
disease severity, eNO levels have shown a significant increase. However, the results from 
different studies are somewhat inconsistent. Consequently, eNO could also be used as a 
biomarker to evaluate the state of the aforementioned pulmonary diseases, as well as to 
monitor the progress of the treatment, but more research is required to confirm this. 
NO is one of the three so called “gasotransmitters”, in addition to H2S and carbon monoxide 
(CO). Gasotransmitters are a special group of gaseous signaling molecules that are used in 
the transmission of chemical signals, in order to induce certain physiological or biochemical 
changes in the organism, tissue or cell. NO is an important biological agent in the human 
body, and has been connected to various physiological functions, such as the regulation of 
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blood pressure, blood flow and vascular permeability. NO is also produced by certain white 
blood cells of the immune system to destroy invading micro-organisms, such as bacteria.51 
NO has also been connected to several neurological functions. It is also especially important 
in the gastrointestinal track and the cardiovascular system, where it aids the relaxation of 
smooth muscle tissue. NO regulates the cardiac contractility and heart rate, and 
consequently, decreased levels of NO are connected to several common cardiovascular 
diseases, such as the coronary artery disease (CAD).55 Their effective treatment also 
generally includes increasing the concentration of bioavailable NO. Decreased level in NO 
synthesis has also been observed in patients with type 2 diabetes,56 which could imply that 
there is a connection between NO and diabetes as well. On the contrary, the excess 
production of NO can lead to life-threatening consequences, such as sepsis51, where the 
immune response to infection also injures the cells of the organism itself.  
NO has proven to be a successful biomarker for asthma, and a few other inflammatory 
diseases of the airways, and as mentioned in the earlier section, the NO breath test is already 
in routine clinical use. However, more research could still be done in order to investigate, 
whether NO could serve as a biomarker for variety of other inflammatory diseases as well, 
since it has been recognized as one of the most important mediators regarding, for example, 
blood flow, neurotransmission, immune reactions, and muscle contraction. Research has 
already been done on NO in exhaled breath of patients with heart failure,57 and these kind of 
studies build a good background for future investigations. It should be mentioned that NO is 
not an inflammation specific biomarker, meaning that it can be difficult to connect its 
concentration changes incontrovertibly to certain organs or medical conditions. This is 
another area of research that needs more attention in the future. 
 
2.2.4 Hydrogen Sulfide 
 
H2S is generally known for its strong and foul smell, and its relation to air pollution and 
industrial processes. However, sulfur is a biologically active element, and consequently, 
many sulfur containing compounds are also extremely important in the human body. H2S is 
toxic in a similar way as HCN, but it exists naturally in the human body in trace amounts, 
and has been recognized as one of the three gasotransmitters, in addition to NO and CO.  
18 
 
 
H2S is produced endogenously in various tissues, and it has many important physiological 
functions in the human body. Studies have suggested that it can both prevent and induce 
tissue damage and inflammation, depending on its concentration and the organ it affects.58 
H2S has also been connected to the condition of the mucosal lining of the gastrointestinal 
system, regulation of blood flow and inflammatory response, much like NO, described in 
the previous section. Decreased levels of H2S can indicate changes in the mucosal lining of 
the digestive system caused, for example, by the overuse of nonsteroidal anti-inflammatory 
drugs (NSAIDs). H2S has also been connected to liver functions, such as the regulation of 
hepatic blood flow, because it dilates and constricts the pulmonary vessels of the human 
cardiovascular system. Consequently, changes in H2S levels could mark liver based 
complications as well. Studies have also shown that in Alzheimer’s disease the brain tissue 
H2S levels are drastically decreased.
59 Problems in the H2S metabolism have also been 
connected to Parkinson’s and Huntington’s diseases,60 and the symptoms have been proven 
to ease, when H2S was supplied to rats with these conditions.
61 One study also demonstrated 
that the concentration of H2S in plasma was reduced in obese individuals and type 2 
diabetics.62 
Even though H2S is connected to many medical conditions, its application to diagnostics as 
a biomarker could be difficult. First of all, H2S is present in significant levels in our 
gastrointestinal system, because of the activity of gut bacteria, and the decomposition of 
sulfur containing amino acids, polysaccharides and lipids. The diverse bacterial flora of the 
oral cavity also produces H2S, and consequently, it has been connected to halitosis. In 
addition, H2S is produced by so many tissues in the human body that it can be challenging 
to separate the contributions from different organs. It can also prove difficult to standardize 
a breath test for a substance that is related to so many different physiological functions in 
the body. However, NO is a similar type of gasotransmitter connected to several 
physiological functions, and yet it is routinely used in the clinical diagnostics. This makes it 
plausible to also consider H2S as a possible breath test biomarker, provided more research is 
done on the subject. A biomarker that could span the neurological, cardiovascular, 
gastrointestinal, genitourinary and endocrine systems, is definitely an inspiring target for 
future investigations. 
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2.2.5 Acetone  
 
Acetone is the second most abundant trace gas in the human exhaled breath, with an average 
concentration of 477 ppb.9 Acetone is a ketone body produced in the liver, and unlike many 
other breath biomarkers, its metabolic pathways are well established. The two sources of 
acetone in the human body are dehydrogenation of isopropanol and decarboxylation of 
acetoacetate. The accumulation of ketones, such as acetone, in the human body is usually 
the result of a disturbed glucose metabolism. This occurs, when the body is not provided, or 
is unable to break down carbohydrates, which are the source of glucose, or glucose cannot 
be used for some reason, for example because of the lack of insulin. Consequently, the 
human body starts to break down fatty acids instead of glucose to gain energy, which results 
in the increased concentrations of ketone bodies in the blood. High levels of ketone bodies 
can lead to the acidification of blood, where the pH value of blood decreases below the 
natural level – a condition referred to as “ketoacidosis”. This condition is common especially 
with type 1 diabetes, where the insulin production is not sufficient enough, insulin action is 
defective, or in some cases both. Mild cases of ketoacidosis can lead to nausea, excessive 
thirst, fatigue, confusion and fainting, but severe cases can be fatal. Patients with diabetes 
also have episodes of high blood sugar in addition to elevated levels of ketone bodies, 
because the glucose in blood is not transferred to the tissues and cells by insulin, as in the 
bodies of healthy individuals. Consequently, it has been hypothesized that since there is a 
connection between the blood ketone and the blood sugar levels, volatile acetone could be 
used as a biomarker for high blood sugar diseases, such as diabetes mellitus. 
The relationship between breath acetone and blood glucose level, which is the clinical 
parameter currently used in the diagnostics and monitoring of diabetes, is not yet understood. 
It is possible that no quantitative relation exists, which would mean that the efforts to 
establish diabetes diagnostics through breath analysis of acetone are inconclusive. However, 
it is also possible that a quantitative relation does exist, but has yet to be established. Many 
studies show that the concentration of acetone in exhaled breath correlates quite strongly 
with the blood glucose level, and elevated breath acetone has been observed, for example, 
with many diabetic patients having elevated blood glucose as well.63 These studies suggest 
that there is indeed a connection between the breath acetone and the blood glucose levels, 
but more research, with significantly larger number of diabetic subjects, is required to 
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unravel the true meaning of this correlation. Various studies have also remarked that there 
seems to be a difference between the breath acetone levels of patients with type 1 and type 
2 diabetes.63 With type 1 diabetes it is quite unanimously agreed and proven that the acetone 
levels in the exhaled breath are elevated, whereas with type 2 diabetes such a clear, consistent 
elevation has not been agreed on. Therefore, it is still unclear, whether acetone could be a 
possible biomarker in addition to type 1, also to type 2 diabetes. In addition to blood glucose 
levels, there is evidence that the blood ketone levels correlate with breath acetone as well.64 
This suggests that it could also be possible to use acetone as a breath biomarker for the 
monitoring of ketone levels in blood, and thus, in the prevention and diagnostics of 
ketoacidosis. Breath acetone has also been connected to fat loss, which is an intriguing 
finding in the modern world, where 39% of the whole adult population are overweight.65 
Diabetes mellitus has been the major area of interest for acetone breath analysis research, 
however, a few other medical conditions have also been linked to elevated acetone levels. 
Congestive heart failure (CHF) has been suggested as a ketosis-prone condition, meaning 
that the patients have an increased risk to develop ketosis – a milder version of ketoacidosis. 
Research results have shown that breath acetone levels are higher in the CHF patients 
compared to healthy controls,66 and that acetone levels also vary with heart failure severity 
and type – acute or chronic.67 It has also been suggested that breath acetone could be used 
in the prognoses of heart failure.68 A positive correlation has also been found between breath 
acetone and heart failure hemodynamic parameters, such as the B-type natriuretic peptide,69 
which further suggests that acetone could be a possible biomarker for the diagnostics and 
monitoring of heart failure. Elevated breath acetone levels have also been observed during 
cardiac surgery. Furthermore, exhaled acetone has shown positive correlation to serum 
troponin-T, a smooth muscle protein used routinely in the diagnostics of heart attack, as well 
as serum C-reactive protein (CRP), a common marker for inflammation.70   
In conclusion, acetone seems to be a promising possible biomarker especially for type 1 
diabetes, ketosis and ketoacidosis, and heart failure. However, the technical aspects of 
acetone breath analysis can prove to be challenging, for example, because it is one of the 
substances that exchange already in the airways, rather than alveoli. This makes it easy to 
underestimate the actual concentration of acetone in blood, which could affect the 
reproducibility of the breath tests. Regardless, future research on breath acetone is desirable, 
because of its the strong correlation to certain medical conditions, such as heart failure and 
diabetes that are major issues in the modern world.   
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2.2.6 Methane 
 
Methane occurs naturally in the gastrointestinal track, where it is produced by various 
bacteria colonizing the mucosal lining. However, sometimes the production of methane can 
increase above the level of normal, due to the malabsorption of certain sugars. Most 
commonly known condition of sugar malabsorption is lactose intolerance, where the 
individual is unable to hydrolyze lactose properly, and this leads to bloating, excessive 
amounts of flatulence, diarrhea, cramps and abdominal pain. The malabsorption of different 
sugars, such as lactose or fructose, results in the excessive production of methane and 
hydrogen by the bacteria of the digestive system. The overproduction of these gasses 
increases the pressure in the gastrointestinal track, which can lead to the unnecessary 
opening of the ileocecal valve between large and small intestines, and this in turn can allow 
the bacteria in the colon to migrate into the small intestines, and cause SIBO. This condition 
can lead to deficiency of vitamins and minerals, as well as malnutrition, because the bacteria 
in the small intestine compete with the host for the same nutrients. SIBO has also been 
connected to depression and stressed immune system, as well as substances that are irritating 
or toxic to the lining of the gastrointestinal track. At the moment, SIBO is diagnosed mainly 
with HBT, because hydrogen is the other main gas produced in the malabsorption of sugars. 
However, it has been shown that the HBT overlooks those individuals, who produce mostly, 
or only methane as a result of the sugar malabsorption, and thus, gives quite high number of 
false negatives. Consequently, it has been shown that in the diagnosis of SIBO, the 
combination breath test of hydrogen and methane is superior compared to the commonly 
used HBT alone.71 
Methane levels in the exhaled breath have been connected to other conditions of the 
gastrointestinal track as well. In diarrhea prone conditions, such as Crohn’s disease and 
ulcerative colitis, excessive methane production is not observed, but in constipation prone 
conditions, like diverticulosis, it is more common. Methane concentrations have also been 
shown to correlate with the severity of constipation.72 In addition to constipation, methane 
has been connected to the slow intestinal transit time,73 and it has been suggested that 
methane could affect the movement of the smooth muscle tissue in the digestive track. The 
results of studies investigating a proposed connection between methane and large bowel 
cancer are controversial and debatable,74 but the area calls for more research. 
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Methane is a suitable biomarker for carbohydrate malabsorption and SIBO, and should be 
used together with hydrogen in the diagnostics of these conditions. The possible connections 
of methane with constipation, slow transit time and cancer are also quite interesting, 
especially in the modern world, where gastrointestinal problems are some of the most 
frequent reasons to seek medical care. However, the effects of endogenous methane are still 
poorly understood, and some of the studies have shown controversial results. In addition, 
methane as a biomarker has not been studied as immensely as some other volatiles, such as 
acetone or NH3, and its potential in the area of breath analysis is still mostly unknown. 
Recently, however, investigations have been made to unravel the endogenous bacterial 
methane generation, and the dynamics of methane elimination through the respiratory 
system.75 Methane could prove to be a noteworthy biomarker candidate in the diagnostic of 
multiple gastrointestinal diseases, in addition to SIBO, and its potential should be 
investigated further in the future.  
 
2.2.7 Summary 
 
Table 1 summarizes the medical conditions connected in previous studies to the small-
molecule volatiles discussed in this chapter. Table 1 also describes briefly the challenges 
concerning the usage of these molecules as breath biomarkers. The aim of this chapter was 
to present the wide range of different diseases and medical conditions that could be 
diagnosed in the future by simple volatiles, such as those six discussed in this thesis. Some 
of these conditions, such as diabetes and heart failure, affect a major part of human 
population, and have a huge effect on the economy of most countries.  Consequently, basic 
and applied research concerning small-molecule volatiles as biomarkers should be continued 
and improved in the future, so that new innovations in healthcare and disease diagnostics 
could be possible. In addition, small-molecule volatiles have some advantageous features 
compared to large VOCs, such as the fact that they produce simpler spectra that are easier to 
interpret – which in turn is desirable considering the analysis and identification of 
biomarkers – and that their metabolic pathways are generally simpler, and thus, easier to 
establish and understand.    
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Table 1. Medical conditions and challenges related to small-molecule volatiles.  
 Possible associated medical condition Challenges 
Hydrogen 
cyanide 
Bacterial infection (P. aeruginosa, oral 
anaerobes),5,27-29 cystic fibrosis,34,35 
periodontal diseases,5 exposure to toxic 
fumes. 
Distinction of the origin (oral, 
blood, other). Distinction 
between normal and abnormal 
levels.  
Ammonia Liver diseases,42 kidney diseases,41,43-45 
bacterial infection (H. pylori),46 
hyperammonemia, encephalopathies.  
Water soluble. Bacterial activity 
of the oral cavity affects exhaled 
levels. 
Nitric 
oxide 
Asthma,52,53 chronic obstructive 
pulmonary disease,54 inflammatory 
airways diseases,54 problems in blood 
flow and pressure, sepsis,51 response to 
bacterial infection,51 coronary artery 
disease,55 cardiac diseases,57 diabetes,56 
neurological diseases. 
Various possible origins, so 
connection to one condition of 
interest can be difficult.   
Hydrogen 
sulfide 
Problems in blood flow and pressure, 
gastrointestinal diseases (e.g. atrophy, 
gastritis, ulceration, changes in mucosal 
lining),58 Alzheimer’s disease,59 
Parkinson’s disease,60 Down syndrome, 
diabetes mellitus,62 liver diseases. 
Bacterial activity of the 
gastrointestinal track and oral 
cavity affect exhaled levels. 
Various possible origins, so 
connection to one condition of 
interest can be difficult.      
Acetone Diabetes mellitus (type 1),63 ketosis and 
ketoacidosis,64 congestive heart failure,66 
other cardiac diseases, obesity.65 
Polar substance, which 
exchanges in different parts of 
the airways.   
Methane Problems of the gastrointestinal track, 
small intestine bacterial overgrowth,71 
constipation,72 slow motility of the 
digestive track,73 large bowel cancer.74 
Still quite poorly studied and 
understood in the field of 
biomarkers and breath analysis. 
Distinction of origin (oral, gut). 
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3. Cavity Ring-Down Spectroscopy 
 
CRDS is a well-established technique based on the direct absorption of light by a gaseous or 
liquid sample. It is an enhanced version of direct laser absorption spectroscopy (DLAS), 
where the laser power transmitted through a sample of interest is detected, and a spectrum 
recorded, as illustrated in Figure 2. The amount of transmitted power depends on the 
absorption of light by the sample molecules, which in turn is dependent on the absorption 
path length, and the concentration and characteristics of the molecular species present in the 
sample. The sensitivity of DLAS is severely limited by the fluctuation of the laser power, 
and consequently, the sensitivity is generally too low for the analysis of trace gases, with 
abundances in the order of 10-6 (parts per million, ppm), 10-9 (parts per billion, ppb) or 10-12 
(parts per trillion, ppt) by volume. Poor sensitivity of DLAS is the main reason for the 
development of alternative, enhanced absorption techniques, which aim to improve the 
sensitivity essentially by either noise reduction or signal enhancement. The first category 
includes reducing the noise, or fluctuation, of the laser power, or moving detection to higher 
frequencies, where the noise from the laser, detector and electronics is smaller. The second 
category, on the other hand, includes increasing the effective path length of absorption.  
 
Fig.2. Basic setup for DLAS, with a tunable laser light source, a sample cell of length L, and 
a detector. Incident light (P0) travels through a sample, which absorbs part of the radiation 
and transmits the rest (P) to the detector, which gives a signal as a function of wavelength, 
and a spectrum is produced.      
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In CRDS, the absorption path length is increased up to several tens of kilometers, which 
improves the sensitivity of basic DLAS significantly, and enables the analysis of trace gas 
species, for example, from exhaled breath. Basic setup of a CRDS instrument consists of a 
tunable laser, a high-finesse cavity with two highly reflective mirrors on each end, a 
photodetector and a data acquisition card (DAQ) connected to a computer, with appropriate 
software for data handling. In addition, the instrument usually requires something for 
wavelength adjustment and laser mode matching. In the next sections the basic theory, as 
well as the advantages and limitations of CRDS are introduced, with the custom built 
instrument of our laboratory used as a descriptive example. CRDS is also compared to other 
relevant techniques used in trace gas analysis. In the last sections, special focus is given to 
sampling of gases, with our custom built sampling line as an example.  
 
3.1 Basic Theory 
 
Pulsed laser light is directed into the ring-down cavity of the instrument, where it first travels 
to the rear mirror, reflects back towards the front mirror almost completely, and travels back 
to the front mirror.  The time light takes to travel from the front mirror to the rear one and 
back, is called the cavity roundtrip-time, and it depends on the cavity length. With the highly 
reflective mirrors of a ring-down cavity, the light can be reflected back and forth thousands 
of times, which increases the effective absorption path length (L) significantly. According 
to the Beer-Lambert law of equation (1), the measured absorbance (A) is directly 
proportional to concentration (c) and absorption coefficient (ε) of the substance, as well as 
the path length. This means that increasing the path length, for example, by highly reflective 
mirrors or longer cavity, the measured absorbance signal increases as well.76 Consequently, 
these sort of cavity-enhanced absorption instruments can be used to detect very small 
concentrations of substances, even down to ppq level.   
    
 𝐴 = 𝑐𝜀𝐿 (1) 
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Small part of the reflecting light leaks through the rare mirror during each contact, and a 
detector downstream measures the intensity of this transmitted light. When the intensity 
reaches a certain threshold, a switch connected to the detector cuts off the laser beam, and 
no additional light enters the ring-down cavity. After this so called “laser switch off”, the 
light in the cavity continues reflecting back and forth between the mirrors, but the intensity 
of this light starts to decay exponentially, because of the cavity losses.76 Consequently, the 
intensity (I) of the light transmitted through the rear mirror also shows an exponential decay 
over time, as described by equation (2). 
 
 
𝐼(𝑡) = 𝐼0𝑒
−
𝑡
𝜏0  , (2) 
 
where 𝐼0 is the intensity of the incident light at laser switch off, t is time and 𝜏0 is the empty 
cavity photon lifetime. 
Photon lifetime, or the ring-down time, in an empty cavity depends on mirror separation (L) 
and reflectivity (R), according to equation (3). 
 
 𝜏0 =
𝐿
𝑐(ln 𝑅)
 , (3) 
 
where c is the speed of light. 
When the cavity is filled with an absorbing sample, the photon lifetime will decrease, 
because of the interaction of the sample molecules with the light. The intensity decay of the 
light in a cavity with an absorbing sample, differs from the empty cavity decay according to 
equation (4), where α is the molecular absorption coefficient and τ is the photon lifetime in 
a cavity with a sample.76 
 
 𝐼(𝑡) = 𝐼0𝑒
−
𝑡
𝜏
−𝛼𝑐𝑡
  (4) 
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The product of speed and time is distance, hence, the product of c and t in equation (4) is the 
absorption path length (L), in other words, mirror separation. The decaying detector signals 
in a cavity with and without a sample are described in Figure 3.   
 
 
 
 
 
 
 
 
Fig.3. Illustration of the decay in light intensity measured by a detector before, and after 
laser switch off. 
The photon lifetime in a cavity with an absorbing sample depends again on R and L, but also 
on the absorption coefficient, as described in equation (5).76 
 
 
𝜏 =
𝐿
𝑐(ln 𝑅 + 𝛼𝐿)
 (5) 
  
The absorption coefficient can be calculated according to equation (6), when the photon 
lifetimes of both an empty and a sample containing cavity are known.76 
 
 
𝛼 =
1
𝑐
(
1
τ 
−
1
𝜏0
) (6) 
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The absorption spectrum is achieved by measuring the time dependence of the light leaking 
out of the cavity, in other words, the photon lifetime, while scanning the laser wavelength 
over the range of interest.76 The photon lifetimes can be further converted into the absorption 
coefficients, which produce absorption spectrum, when fitted as a function of wavelength or 
wavenumber, as seen in Figure 4. 
 
Fig.4. Typical absorption spectrum from a gaseous sample of HCN. Two Voigt functions 
are fitted into the experimental data points, one for CO2 (larger peaks) and another for HCN 
(smaller peak). The sum of these two Voigt functions is shown here as a red least-squares 
fit. 
It is possible to determine the concentration of the species of interest in the sample from the 
peak area in the spectrum. Absorption coefficient can be related to the number of absorbing 
molecules (N) according to equation (7).77 
 
 
∫ 𝛼(?̃?) 𝑑?̃? = 𝑆𝑇𝑁 (7) 
 
where ST is the spectral line intensity for a certain molecule per unit volume, and the 
integrated absorption coefficient equals the peak area and is dependent on the wavenumber 
(?̃?).  
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The absorption coefficient integral can be approximated, when the normalized line shape 
function of the peak is known. As the absorption peaks are never indefinitely narrow, these 
line shape functions take into account the broadening of the peaks. Every absorption line has 
a natural linewidth, which arises from the fact that the lifetime of an energy state is never 
infinite. However, the natural linewidth is usually very small compared to the other main 
line broadening mechanisms – pressure and Doppler broadening. In pressure broadening, the 
lifetime of the upper state is limited by the collisions between molecules, the number of 
which is dictated by the pressure of the sample. Doppler broadening, on the other hand, is 
caused by the variance in velocities of different atoms or molecules relative to the detector. 
The combined effect of these two broadening mechanisms can be accounted for, with the 
convolution of the line shape functions for both pressure and Doppler broadening. The 
convolution is called a Voigt function, also mentioned in Figure 4.78 
Integrating a line shape function, such as the Voigt function, results in peak area, which can 
be used together with line intensity to determine the concentration (c) of a sample, according 
to equation (8). 
 
 
𝑐 =
𝑁
𝑁𝐴
=
∫ 𝛼(?̃?) 𝑑?̃?
𝑆𝑇𝑁𝐴
, (8) 
  
where NA is Avogadro’s constant. The line intensities for specific transitions needed in the 
calculation of concentration, can be obtained from a spectral database, such as HITRAN, 
and converted into correct values for specific temperatures, if needed. 
Each molecule has a unique structure, and a unique absorption spectrum, where the peaks 
correspond to transitions between different energy states. Absorption in the infrared (IR) 
region results in the excitation of vibrational and rotational states, and the recorded spectrum 
contains peaks from the vibrational transitions and their rotational fine structure.79 
Sometimes only a small portion of the infrared spectrum is examined, as in Figure 4, where 
only peaks from a certain vibrational excitation and associated rotational fine structure are 
observed. In the case of HCN in Figure 4, the examined peak results from a rotational 
transition – from a state with a rotational quantum number J=5 to a state with J=4 – of the 
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first H-C stretching vibration overtone. Figure 5 illustrates a larger portion of an IR 
spectrum, where the aforementioned HCN peak can be seen in the far right. 
 
Fig.5. Region of interest in an IR spectrum obtained with CRDS.39 
 
3.2 Cavity Modes and Interaction of Waves 
 
Laser light confined in the ring-down cavity can experience interference, when it reflects 
back and forth between the two mirrors. Interference happens when two waves are coherent, 
in other words, when they have the same, or nearly the same frequency. When light waves 
interact destructively, the wave that results, has a smaller amplitude than the initial waves. 
Destructively interacting waves have a phase difference (𝜃) of: 
 
 𝜃 = 𝑛𝜋, (9) 
 
where n is an odd integer.  
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When interfering constructively, the interacting waves sum up to form a wave, with larger 
amplitude than the initial ones. The phase difference of constructively interacting waves is 
 
 𝜃 = 2𝜋𝑛, (10) 
 
where n is an integer. 
The phase difference determines whether the waves weaken or reinforce each other. The 
resulting wave has a maximum amplitude, when the two interacting waves are completely 
in phase, and a minimum amplitude, when they are completely out of phase (antiphase). 
When the phase difference between two interacting waves is something between the two 
extremes, the amplitude of the resulting wave is also somewhere between the minimum and 
maximum. Constructive and destructive interference of two waves are described in Figures 
6 and 7, respectively. 
 
 
Fig.6. Constructive interference of two coherent waves results in a new wave, with a larger 
amplitude. If the interfering waves are in phase, the amplitude of the resulting wave is the 
sum of the individual amplitudes.  
 
Fig.7. Destructive interference of two coherent waves results in a new wave, with a smaller 
amplitude. If the interfering waves are in antiphase, the amplitude of the resulting wave is 
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the difference of the individual amplitudes. Interaction of two waves in antiphase with equal 
amplitudes results in the cancellation of the wave. 
A wave, with large amplitude carries higher amount of energy compared to a wave, with a 
smaller amplitude. Energy carried by a light wave is connected to the intensity of the light, 
and consequently, constructive interference results in the increase of the light intensity, 
whereas destructive interference results in the opposite. In a ring-down cavity the 
constructive interference is essential, and it is reached when the reflections at mirrors happen 
at the nodes of the waves. The constructive interference of travelling waves in the cavity 
creates standing waves that are characteristic for different resonant frequencies, or modes, 
of the cavity. Consequently, a ring-down cavity has specific modes created by the different 
patterns of standing waves. The most stable wave patterns – those that remain in the cavity 
through each reflection – are called the eigenmodes of the cavity. There are two kinds of 
eigenmodes modes: longitudinal and transverse.76 In a standing-wave cavity, resonance can 
be achieved when the length of the cavity is 
 
 𝐿 = 𝑛
𝜆
2
= 𝑛
𝑐
2𝑣
 , (11) 
 
where 𝜆 is the wavelength, 𝑣 is the frequency, c is the speed of light and 𝑛 is a positive 
integer (mode number). 
The resonance frequencies related to equation (11) are the longitudinal modes of the cavity, 
and each mode has its own frequency. Frequency separation (∆𝑣) between two consecutive 
longitudinal modes is called the free spectral range (FSR) of the cavity, and it is defined in 
equation (12). 
 
 𝐹𝑆𝑅 = ∆𝑣 =
𝑐
2𝐿
  (12) 
 
A transverse electromagnetic mode (TEM) is a particular electromagnetic field pattern of 
radiation, measured in a plane perpendicular to the propagation direction of the light beam. 
They are denoted TEMnm, where n and m are integers labeling the radial and angular mode 
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orders, respectively. Different transverse modes have different frequencies, as well as 
different intensity patterns throughout the light beam. When the radial and angular mode 
orders are both zero, the resulting transverse mode is called the fundamental transverse mode 
of the cavity (TEM00). It is the lowest order transverse mode, and its intensity pattern has a 
simple circular structure of a Gaussian beam, illustrated in Figure 8. Every TEM can be 
excited, and they can all decay separately, which can cause disturbance to the measured 
signal. Consequently, only the TEM00 mode of the cavity is usually excited with the laser 
light, so that the disturbance from multiple exited modes can be eliminated.76 
 
Fig.8. Spatial distribution of the TEM00 mode, which has a Gaussian cross section, and the 
TEM10 mode, with a much more complex beam profile. 
Modes are important aspect of any cavity-enhanced technique, since only absorptions that 
happen within the eigenmodes of the cavity can be measured. In addition, mode matching is 
an essential feature of cavity-enhanced absorption spectroscopy, because it assures that only 
the desired cavity modes are exited, and consequently, multimode excitation is avoided.  
 
3.3 The Cavity Ring-Down Instrument 
 
As mentioned earlier, basic setup of a CRDS instrument consists of a tunable laser, a high-
finesse cavity with two highly reflective mirrors on each end, a photodetector, an 
oscilloscope and a computer, with appropriate software for data handling. 
Lasers used in CRDS can be narrowband continuous wave (CW) lasers or broadband pulsed 
lasers, both of which need to be tunable over a certain wavelength range, in order to measure 
high-resolution spectra. Typical lasers in CRDS instruments are semiconductor lasers, such 
34 
 
 
as laser diodes or quantum cascade lasers, and solid-state lasers, such as titanium-sapphire 
lasers. The wavelength range needed to observe a transition of interest determines, which 
laser is suitable for the application, however, the cost and power uptake of the laser should 
also be considered, especially with field-instruments. In laboratory environment, even lasers 
that require extremely high amounts of power are possible to use, but with field-applications 
available power is significantly lower, which has to be taken into account, when choosing a 
suitable laser. CW lasers are usually cheaper and require less power, but they provide only 
a narrow wavelength range. In contrast, pulsed lasers are more expensive and can require a 
significant amount of power, but have a wide wavelength range, and can provide pulses of 
light in the order of picoseconds or even less.76 
Mirrors used in the cavity of a CRDS instrument are required to be highly reflective 
(R>99.9%) and suitable for the wavelength range of the light emitted by the laser. They 
should also be sufficiently small, when considering a cavity in a portable instrument.76 
Mirrors are usually the most vulnerable part of the CRDS instrument, and can be easily 
contaminated, for example, by moisture. Therefore, a system to protect the mirrors, such as 
moisture traps or filters, are usually included in the instrument.  
There are various suitable detectors for CRDS.  They have to be able to detect the changes 
in light intensity, and convert the signal from electrical to digital form. Commonly used 
detectors are photomultiplier tubes and photodiodes, such as indium gallium arsenide IR 
detector.76 Computer connected to the detector is required to have appropriate software for 
reading the digital signal produced, and for data handling, which includes the fitting of line 
shape functions into the spectrum. Wavelength adjustments of the laser can be done by a 
computer software or an oscilloscope. In addition, oscilloscope is useful for monitoring the 
quality of the signal during the measurements, and when adjusting the mirror positions or 
mode matching optics.   
Our custom built instrument, described in Figure 9, has some additions compared to the basic 
setup described above. Faraday isolator protects the laser by decreasing the amount of 
radiation returning back to the laser from elements downstream. An acousto-optic modulator 
(AOM) diffracts and sifts the frequency of the light, and light from the first order of 
diffraction is passed through. Mode matching telescope ensures that only the TEM00 of the 
cavity is excited by the laser light. The instrument also has two piezoelectric sensors, one of 
which is attached to the rear mirror of the cavity, and used for smoothing out the measured 
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signal, and consequently, the spectrum. The ring-down cavity used in our custom build 
instrument is 0.517 meters long, and the total sample volume is 50 milliliters. The walls of 
the ring-down cavity are stainless steel, but the inner surfaces are coated with silica, which 
provides a non-reactive surface. Our instrument has mirrors with reflectivity of 99.997%, 
and they are suitable for the wavenumber range of 6290–6850 cm-1 The empty cell ring-
down time of the cavity is roughly 100 µs. Near-infrared (NIR) CW light used in our 
measurements is produced by a single-mode external cavity diode laser, which is tunable 
over the wavenumber range of 6350–6575 cm-1, has a bandwidth of roughly 1 MHz and 
output power of 20 mW.   
Fig.9. Representation of the optical part of a custom build CRDS setup. Red lines are laser 
beams and grey lines are signal cables. 
 
3.4 Advantages and Limitations 
 
One of the major advantages of CRDS, especially considering breath analysis, is the 
possibility for real-time measurements, where the sample can be breathed directly into the 
instrument, and breath components monitored in real-time. This enables the detection of 
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volatiles in exhaled breath instantly, and without the need to first collect the sample into a 
bag or a container, which can affect the detected levels negatively. Real-time measurements 
are rarely possible with techniques that require sample preparation or pre-concentration, for 
which there is no need with CRDS.76 This gives a significant advantage on CRDS compared 
to, for example, many MS techniques. Laser based instruments are also usually relatively 
robust and easy to use, even without special knowledge about the technique, which makes 
them attractive, for example, in the field of healthcare. The amount of expensive laboratory 
work and treatment time can be reduced, when the immediate healthcare personnel, such as 
nurses and medical doctors, are able to use the analysis instruments themselves. 
CRDS is also a highly sensitive technique, with which concentrations of volatiles even down 
to ppq level can be measured. As mentioned earlier, the sensitivity of absorption 
spectroscopy is proportional to the absorption path-length, and by increasing it, high 
sensitivity can be gained. In CRDS, the path-length can be increased significantly, even up 
to several kilometers, without simultaneously increasing the size of the instrument. 
Consequently, CRDS combines high sensitivity with small size, which saves space in 
hospitals, and makes it possible to introduce this technique to clinical field work. Measured 
signal in CRDS is independent of the fluctuation in the laser power, because the time 
behavior of the intensity signal is measured instead of transmitted power. This means that 
laser power fluctuation does not cause noise to CRDS measurements, as it does with most 
other LAS techniques, and consequently, laser noise does not restrict the sensitivity of 
CRDS. In addition, changes in the light source between measurements introduce no error to 
successive results. In CRDS, the absorption is also measured on an absolute scale, which 
makes it more appealing compared to those absorption techniques that use some sort of 
modulation schemes. There is also no need for calibration with CRDS, because the 
absorption coefficient is achieved inherently from the decay time.76 
The main limitation of CRDS, and LAS techniques in general, is that it can only be used in 
the analysis of fairly small molecules. As mentioned in the previous chapters, the vibrational 
spectra of large molecules are usually hard to interpret, because of the overlapping of 
different absorption bands. This is why CRDS is usually used for simple molecules, like 
HCN or NH3, which only have a few vibrational modes that can be excited, and thus have 
fairly simplistic vibrational spectra. Water contained by a sample can also interfere with the 
measured spectra, and its signal often overlaps with the peaks of the substances of interest. 
The effect of water has to be taken into account, when measuring with CRDS, by minimizing 
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its concentration in the sample, or searching for a vibration peak of the substance of interest 
in a wavelength range, where water does not interfere. When larger biomarkers are studied, 
alternative analysis techniques need to be used. Other limitations of CRDS include the cost 
of lasers and mirrors, which can in some cases be rather high. High-power laser, often needed 
in the IR region in order to reach small concentrations, can be quite costly, and they also 
require large amount of power, which might not be possible to supply in field-applications. 
Cavity mirrors are also sensitive to contamination, which can affect sensitivity and bring 
challenges to the instrumentation. CRDS is ideal in the NIR region, but when moving to the 
mid infrared (MIR) region, the sensitivity of this technique decreases significantly. This 
results mainly from the lack of suitable mirrors in the MIR region.80 
Resolution of CRDS, and the accuracy of the measured decay time, are dependent on correct 
mode matching between laser and the ring-down cavity. Laser linewidth must overlap with 
one or more spectral modes of the ring-down cavity, and usually it is also desired that only 
one cavity mode is excited, because multimode excitation makes the result interpretation 
significantly more challenging, as each mode can decay at its own rate. Sometimes mode 
matching can prove to be difficult, which can make the instrumentation tedious. Multi-
exponential decay can occur, if all the frequencies in the laser bandwidth are not equally 
reflected by the mirrors, and can result in more complicated spectra. This happened 
especially with frequencies close the edge of the mirror’s reflected wavelength region. 
 
3.5 Comparison to Other Techniques 
 
This section introduces the main features of the most commonly used analysis techniques 
for trace gas breath analysis. Their advantages and limitations are also discussed, and 
compared to the features of CRDS. A few examples of instrumental limit of detections 
(LODs), reached in earlier studies for small-molecule biomarkers, are given as well.  
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3.5.1 Mass Spectrometric Techniques 
 
Traditionally, mass spectrometric techniques have been the most used in the field of breath 
analysis, and the “gold standard” for volatile biomarkers has been the combination of gas 
chromatography and mass spectrometry (GC-MS). Other relevant mass spectrometric 
techniques, especially for VOC analysis, are selected ion flow tube mass spectrometry 
(SIFT-MS) and proton transfer reaction mass spectrometry (PTR-MS). The core idea of any 
MS technique is to create ions from the molecules in the sample of interest, and separate and 
detect these ions according to their mass-to-charge ratio (m/z). What differs between 
different MS techniques, however, is the method through which this ionization is achieved. 
There is multitude of different ionization techniques, but only some of them are suitable for 
analysis of gaseous samples – these include electron ionization (EI) and chemical ionization 
(CI). In EI the sample molecules are bombarded with electrons, which creates neutral or 
positively charged fragment molecules.  EI is a so called “hard” ionization technique, which 
means that the ionization results in a high number of fragmented sample molecules, and thus 
more complicated spectra. However, fragmentation is extremely useful in the structure 
determination, and consequently, identification of unknown molecular species. CI, on the 
contrary, is a “soft” ionization technique, which creates less fragmentation, and simpler 
spectra. In CI, the sample molecules are ionized by collision with ions of reagent gas 
molecules, such as methane or ammonia. PTR-MS and SIFT-MS both use chemical 
ionization, but in the analysis of volatiles with GC-MS, either one of the aforementioned 
ionization techniques can be used.81 
GC-MS has been, until recent years, the most used analysis technique for volatile 
biomarkers, and in breath analysis. It combines the powerful advantageous features of gas 
chromatographic separation and mass spectrometric analysis of the sample. A gas 
chromatograph separates the molecules in a sample according to their chemical properties, 
and their affinity to the stationary phase inside the column of the instrument, as the sample 
travels through it. Some of the molecules are retained in the column longer than others, and 
thus, different components of the sample come out from the column at different times. This 
allows the mass spectrometer downstream to capture, handle and analyze the sample 
components separately. The most important advantage of GC-MS is its high capacity to 
separate sample components, and consequently, its much finer degree of substance 
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identification than either technique can achieve separately. GC-MS is perfect for 
multicomponent analysis, and connecting multiple MS units in a so called “tandem mass 
spectrometry” provides the possibility to gain even higher separation, which makes the 
technique even more sensitive. This pushes detection down to the ppt level. GC-MS is 
suitable for a wide range of substances, from small size molecules to large ones. Limitations 
of GC-MS, especially considering analysis of volatile biomarkers, is the measurement time, 
which can in worst cases be hours. GC-MS is not, therefore, suitable for real-time analysis. 
Samples also usually require some pre-concentration or preparation, which makes online 
sampling impossible.81 The term “online” is used, when the sample can be introduced 
straight into the measuring instrument without the need to actually collect it first. For 
example, in breath analysis the sampling type is said to be online, if the breath sample can 
be breathed directly into the analyzer. The term “offline”, on the other hand, refers to 
sampling techniques that require the collection of breath sample, before they are introduced 
to the measurement instrument. For example, collecting the breath sample into a sample bag, 
and introducing it to the analyzer after this, is a type of offline sampling. GC-MS instruments 
are generally quite large, and therefore not portable. They are also expensive, require 
expertise to use, and the spectral interpretation can be challenging. These disadvantages are 
the main reason, why researchers have sought alternative techniques to use in the field of 
volatile biomarker analysis.           
In PTR-MS, the ionization occurs through proton transfer from a source molecule, which is 
usually hydronium (H3O
+), to the sample molecule. In SIFT-MS a precursor species, H3O
+, 
NO+ or O2
+, is selected to perform the chemical ionization of the sample molecules instead. 
Both PTR-MS and SIFT-MS are widely used in the analysis of different VOCs, and they 
both have many advantageous features. They can be used for real-time measurements and 
online sampling is possible, which make these techniques appealing to breath analysis. SIFT-
MS is generally considered less sensitive compared to PTR-MS, due to the mass filter, which 
selects the precursor ion to be used, but nowadays both techniques can detect concentrations 
down to the ppt level. Some modern PTR-MS instruments are able to detect extreme trace 
concentrations of smaller than 1 ppt.  SIFT-MS has the advantage that it can use three 
different ionizing species instead of just one, which allows the analysis of wider range of 
compounds. Substances, with low proton affinity, such as HCN or H2S, are less prone to 
accept protons from the precursor molecule, which makes their analysis with the proton 
transfer reaction challenging. Also, some molecules do not react with H3O
+ at all, which 
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makes them impossible to analyze with traditional PTR-MS, however, this limitation has 
been overcome by a technique called selective reagent ionization mass spectrometry (SRI-
MS), where H3O
+, O2
+ and NO+ can all be used as precursors. One clear advantage of SIFT-
MS compared to PTR-MS is that no electric field is needed, and it is therefore, possible to 
carry out ion-molecule reactions under thermal conditions, where the kinetic behavior of the 
reactions is well known. Both of these techniques are highly selective and suitable for 
multicomponent analysis, and the range of molecules that can be analyzed with them is quite 
wide.81  
Compared to CRDS, PTR-MS and SIFT-MS are equally sensitive and selective, they are 
both capable of online sampling and real-time analysis, and require no frequent calibration 
or sample preparation. The instruments are sufficiently compact and easy to use nowadays, 
can be made into a portable size, and are not as expensive as GC-MS instruments. PTR-MS 
and SIFT-MS are also suitable for multicomponent analysis, which CRDS is not, and they 
can analyze wider range of compounds compared to CRDS. However, the spectral 
interpretation of SIFT-MS and PTR-MS data is usually complex, and measurement of 
substances with low proton affinity can be challenging. Consequently, SIFT-MS and PTR-
MS are good alternatives, or complimentary techniques, for CRDS considering breath 
analysis, and should be used especially in the analysis of larger, more complex molecules, 
which are not suitable for laser based techniques. 
MS techniques have been used in the breath gas measurements of the small-molecule 
biomarkers reviewed in chapter 2. Limit of detection (LOD) for acetone,38,82,83 ammonia,38,83 
HCN38,35 and methane84 measured with SIFT-MS was 0.5–1 ppb. In another study, LOD for 
H2S and NO measured with a soft ionization MS instrument was 0.1 ppb.
85 HCN and acetone 
have also been analyzed with PTR-MS instruments having LODs in the range of a few 
ppt,86,87 however, the HCN concentrations are underestimated in PTR-MS, because of the 
low proton affinity.  
 
3.5.2 Laser-Based Techniques  
 
In addition to CRDS, other LAS techniques are also used in the trace gas analysis, because 
of their high sensitivity. Tunable, narrow linewidth lasers generally used with LAS 
41 
 
 
techniques provide high selectivity and good spectral resolution, and they operate in the IR 
region of the electromagnetic spectrum, where molecules have their fundamental vibrations. 
As mentioned earlier, DLAS can be enhanced by several methods, one of which is shifting 
the detection to higher frequencies, where especially the laser noise is reduced. Tunable 
diode laser absorption spectroscopy (TDLAS) utilizes this feature by modulating the 
wavelength (TDLAS-WM) or the frequency (TDLAS-FW), so that better signal-to-noise 
ratio is achieved. With these modulated techniques LODs from the ppm to ppb level can be 
reached.80 
Another highly sensitive enhanced absorption technique is photo-acoustic spectroscopy 
(PAS). Its basic principle of action is similar to other LAS techniques, but instead of 
detecting changes in light intensity, PAS measures the pressure change of the sample matrix. 
After molecules are excited with laser light, they can relax back to the lower energy states 
by emitting photons, or through collisions with other sample species. Consequently, part of 
the absorbed optical energy is converted into translational energy of the molecules, which 
leads to the expansion of the sample matrix, and thus, increase in pressure. This pressure 
change can be detected with a suitable sensor, such as a microphone, and an acoustic signal 
generated. The radiation source frequency is modulated so that the pressure changes 
periodically, which gives rise to the acoustic signal. Advanced PAS techniques, such as 
quartz−enhanced photoacoustic spectroscopy (QEPAS), can nowadays achieve very high 
sensitivity, down to ppt level, at least in laboratory environment. However, in order to reach 
the highest sensitivity, PAS technique lasers require power at the level of tens of milliwatts, 
which can be difficult to achieve, especially in field-applications. Considering breath 
analysis, more reasonable detectable concentrations with PAS are in the ppb level. PAS is a 
good alternative for CRDS, especially in the MIR region, which is problematic for CRDS, 
because of the relatively low photodetection responsivity, as well as lack of available 
mirrors.80 However, its sensitivity in breath analysis is still not as high as with CRDS, and 
the high power requirement limits its applicability in field-measurements.  
Another LAS technique used for trace gas analysis is the multi-pass cell spectroscopy 
(MPS), which aims to increase the absorption path length, much like CRDS, and 
consequently, also increase its LOD. Different sorts of cells have been designed for MPS, 
but the main principle remains – light travels through the sample containing cell multiple 
times before exiting, which increases the effective path length. The sensitivity of MPS is not 
as high as with CRDS, because the path length is about three orders smaller (<100 m), and 
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it does not generally reach the sensitivity of PAS either. In addition, laser power noise affects 
the LOD of MPS instruments significantly. However, MPS can be used when neither 
sensitive enough photodetectors, suitable mirrors or high power semiconductor lasers are 
not available, and thus, CRDS and PAS cannot be used.80  
One of the more resent advancements in the trace gas analysis is the optical frequency comb 
assisted spectrometry (OFCS), where an optical comb is produced by a femtosecond mode-
locked laser. The optical comb is essentially a spectrum, which consists of a series of 
equidistantly narrow lines spanning tens or hundreds of nanometers. Measurements done 
with optical frequency combs are equivalent to simultaneously measuring with thousands of 
narrow synchronized laser lines. OFCS combines a wide optical bandwidth and high spectral 
resolution, which are extremely desirable considering trace gas analysis. Because of its high 
sensitivity, and the possibility to simultaneously detect multiple molecular species in a short 
amount of time, OFCS has been proposed as “the ultimate tool” for trace gas detection. 
However, there are challenge in using frequency combs for broadband spectroscopy. To 
exploit the frequency accuracy and spectral resolution provided by the frequency comb 
structure, each individual comb tooth needs to be spectrally resolved. Comb light could, of 
course, be coupled into a conventional spectrometer, but since the comb tooth spacing is 
generally finer than the resolution of any spectrometer, the comb would act only as a very 
bright, collimated light source, and associated frequency resolution and accuracy would be 
lost. To utilize the full potential of the underlying comb structure a technique called dual-
comb spectroscopy (DCD) has been developed. In DCS, two optical frequency combs are 
interfered, to enhance the frequency resolution, spectral coverage and the brightness of the 
beam even further.88 OFCS instruments are still mostly laboratory-based, and much progress 
has to be made in order to apply this technique more widely, for example, to breath gas 
analysis. OFCS has much potential, and when the technology is further improved, it will 
undoubtedly become an important tool for volatile biomarker measurements.  
Different laser based techniques have also been widely used in the breath gas measurements 
of the small-molecule biomarkers introduced in earlier chapters. Methane has been measured 
with PAS instruments having LODs of 0.3 ppm,89 0.25 ppm75 and 64 ppb.90 Ammonia levels, 
on the other hand, where observed with PAS, MPS and CRDS, having LODs of 100 ppb,44 
3–4 ppb91 and 50 ppb92, respectively. NO has been measured with TDLAS and CRDS, 
having LOD of 2 ppb93 and 7 ppt,94 respectively. In addition, HCN has been measured with 
CRDS instrument having LOD of 140 ppt39, and acetone with two different CRDS 
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instruments having LODs of 580 ppb95 and 0.13 ppm.96 H2S, on the other hand, has been 
observed down to 500 ppb, with PAS, and down to 4–8 ppm, with MPS.97 
 
3.5.3 Ion Mobility Spectrometry 
 
In IMS, gaseous sample molecules are ionized, much like in MS, and afterwards, the sample 
molecules are separated based on their mobility in a carrier gas, under the effect of an electric 
field. IMS techniques are sufficiently sensitive, with detections down to ppb level, but 
compared to LAS and MS techniques the selectivity is low. However, IMS instruments can 
be made into a very small size, even down to a few millimeters, which makes them easily 
handheld and portable. They are also not extremely expensive, however, IMS is often 
combined with other techniques, such as GC or MS, to increase its sensitivity, which also 
increases both the size and cost of the instrument. Online sampling is possible with IMS, and 
measurements occur within seconds from sampling, which is not real-time. Multicomponent 
analysis is possible with IMS. One major advantage compared to MS techniques is that no 
vacuum systems are needed with IMS, and ambient air can be used as a carrier gas. These 
features are advantageous considering volatile biomarker analysis, but often fall short 
compared to LAS and MS techniques, which are extremely sensitive, selective, and suitable 
for online sampling, as well as real-time analysis.98 One major shortcoming of IMS is that 
the technique is nonselective, which makes it unsuitable for the analysis of unknown 
substances, however, combining it with MS is often used to overcome this limitation. 
A few examples of high-sensitivity IMS instruments have been used in breath analysis of 
small-molecule volatiles.  IMS has been used in the measurement of ammonia from the 
human exhaled breath, with LOD in the sub-ppb level.98 Acetone levels from breath were 
observed with a IMS instrument having LOD of 1 ppt,99 and the LOD for NO measured with 
IMS was 1.4 ppb.100  
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3.5.4 Sensors 
 
Most of the different commercial analyzers already used in the routine analysis of certain 
volatiles, such as ethanol, are sensors, or so called “electronic noses”. Different sensors 
function in various different ways, relying for example, on electric current or sound waves, 
which are ultimately converted into the amount of molecules in the sample. Until recently, 
the existing materials for sensors have been mostly conductive polymers, semiconducting 
metal oxides, or a combination of these two. Examples of sensors used in breath analysis are 
quartz crystal microbalance (QCM) and the surface acoustic wave (SAW) devices, which 
are mass-sensitive. For example, in QCM sensors gas molecules are adsorbed on the surface 
of a quartz crystal during sensor exposure to a gaseous sample, which leads to changes in 
the mass and resonant frequency of the crystal. Sensors are cheap, small and easy to use 
compared to other techniques discussed here, however, they are not extremely sensitive, with 
LODs in the ppm and ppb level, or reliable. Sensors are usually unable to differentiate 
between compounds that are similar in structure, size or chemical properties, and they are 
nonselective, meaning that identification of unknown components is not possible. Sensors 
are also sensitive to differences in humidity, temperature and sample size, and changes in 
these aspects between different measurements can cause significant error to the result.101 
Consequently, current goals for sensors consist of finding materials with high sensitivity, 
good selectivity and low response to temperature and humidity changes, in order to reliably 
detect increasingly smaller levels of volatile molecules. 
Advantages of sensors are their low cost, small size and the fact that they are easy to 
manufacture. However, they are not ideal for sensitive, accurate and selective measurement 
of volatiles, which is essential in disease diagnostics. Consequently, other more sensitive 
techniques should be developed further, in order to make them more compact, cheap and 
easy to use, so that in the future they could be considered more applicable in biomarker 
analysis and clinical work. New sensor materials and methods should also be developed in 
the future, for more sensitive and selective detection of volatiles, with these cheap and 
conveniently sized instruments. 
A few examples of sufficiently sensitive sensors for small-molecule volatiles have been 
developed. A portable acetone sensor consisting of Si-doped epsilon-WO3 nanostructured 
films has an instrumental LOD of 20 ppb, and robust sensor response against changes in 
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breath gas humidity.102 Another device for measuring human breath ammonia was developed 
based on printed polyaniline nanoparticle sensor, and ammonia concentrations form 40 ppb 
upwards could be observed.45 
 
3.5.5. Summary 
 
Table 2 summarizes the main features, as well as the advantages and limitations of the 
analysis techniques introduced and discussed in the previous sections. Special emphasis is 
given to the features relevant in breath analysis, such as selectivity, sensitivity and sampling. 
Table 2. Summary of the main features of the different analysis techniques discussed in the 
previous sections. 
 LAS MS IMS Sensors 
LOD ppt (CRDS, 
PAS, OFCS) 
 
ppb (TDLAS, 
MPS) 
ppt (PTR-MS) 
 
 
ppb-ppt (SIFT-
MS, GC-MS) 
ppb-ppt ppm–ppb 
Sampling Online and 
offline 
Offline (GC-MS), 
Offline and online 
(PTR-MS, SIFT-
MS) 
Online and 
offline 
Online and 
offline 
Measurement 
time 
Real-time Real-time (PTR-
MS, SIFT-MS) 
Hours (GC-MS) 
Seconds Real-time, 
seconds 
(depending on 
sensor type) 
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Table 2. (continued) Summary of the main features of the different analysis techniques 
discussed in the previous sections. 
Advantages Selective, 
sensitive, easy 
to use and 
build, no 
calibration, 
small, portable 
Selective, all 
molecule sizes, 
suitable for many 
substances, 
multicomponent 
analysis possible 
Easy to use, 
cheap, small 
size, 
multicomponent 
analysis. 
Cheap, fast, 
small, easy to 
use and 
manufacture 
Limitations Only for small 
molecules, no 
possibility for 
multicompone
nt analysis 
(except with 
OFCS). 
Calibration 
needed, large, 
expensive, 
challenging to 
use, complicated 
spectral 
interpretation. 
Not selective, 
low sensitivity 
Not selective, 
low sensitivity, 
responds to 
temperature 
and humidity 
changes. 
 
 
3.6 Measurement of Volatiles 
 
The basic concept of measuring concentrations of volatile molecules from a sample by 
CRDS is fairly simple. Gaseous sample is introduced to the cavity of a CRDS instrument 
described earlier in this chapter, and after equilibrium is reached, the measurement is 
initiated. However, some additional steps are usually required before the sample is allowed 
to reach the cavity. As mentioned earlier, the mirrors in the ring-down cavity are the most 
fragile and often expensive part of a CDRS instrument, and therefore, have to be well 
protected from contamination of any kind. Depending slightly on the sample of interest, the 
possible contaminants are numerous, and they should all be taken into account, when 
designing how the sample is introduced to the instrument. Some sort of sampling line, with 
moisture traps and filters, is generally used in order to prevent contamination, and also, to 
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keep the measurement signal of the instrument as clear as possible. Two different 
measurement areas, and the sampling techniques associated with them, are described in the 
next sections, with our custom built sampling line given as an example.  
 
3.6.1 Bacterial Headspace Measurements 
 
The sampling line of a CRDS instrument can be constructed in multiple ways, but certain 
aspects should always be considered, regardless of the type of the measurement setup. First 
of all, the sampling line material has to be such that it does not react with the components of 
the sample, otherwise the measured concentrations will be affected. Sample molecules can 
also diffuse through the sampling line walls, or stick to them by adhesion, which can further 
affect the measured concentrations by decreasing the amount of sample molecules or 
increasing the background signal. Aspects that should be taken into account, when designing 
the sampling line and choosing the materials, are the reactivity, solubility, polarity, and 
hydrophilic and hydrophobic properties of the sample molecules. Condensation of water 
onto the inner surfaces of the sampling line can also lead to errors in measured 
concentrations, because sample molecules can easily dissolve in the moisture. Excess water 
can also contaminate the ring-down cavity by condensing onto the mirror surfaces. In order 
to avoid this condensation of water onto the surfaces of the sampling line or the cavity, some 
sort of heating system should be used. Bacterial headspace samples generally contain a lot 
of moisture, and in addition to good heating, reliable measurements also require a moisture 
trap of some kind. The sampling line should also be fairly simple, so that the condensation 
and adsorption area is as small as possible. In addition to these features, CRDS setup for 
volatiles generally includes a pump, which is used to create a vacuum in the ring-down cavity 
and sampling line, before the sample is introduced, and also to flush the setup clear after 
measurements. In a one-point measurement – where the sample is introduced to the cavity, 
the cavity is closed and a measurement is taken – the sample flow rate into the cavity is 
usually controlled with a flow-controller or a needle valve, in order to ensure that the 
pressure in the cavity increases steadily when filled, and does not go over the maximum, 
which could damage the mirrors. On the other hand, in a continuous measurement – where 
the gaseous sample flows through the instrument throughout the measurement – the 
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controlled flow rate ensures a steady and consistent introduction of the sample into the 
cavity. A typical sample flow rate could be, for example, 500 mL/min. 
Our custom build sampling line, presented in Figure 10, is mainly constructed from Teflon 
tubing, which connects the different parts of the setup. Gaseous sample is directed into the 
ring-down cavity through a moisture trap and a Nafion tube. Nafion tubing removes gases 
from the sample according to their affinity to sulfuric acid, and therefore, absorbs water 
effectively. Water permeates from one sulfonic group to another, until it reaches the outside 
wall of the tubing, and evaporates into the ambient air. Moisture traps, on the other hand, 
can be of various kinds, but in our setup we use a cold trap, which condenses moisture from 
the sample into liquid form, and thus extracts water vapor. The tubing of our sampling line, 
as well as the ring-down cavity, is kept at a proper temperature (>37 °C) to ensure that the 
condensation of water stays at minimum. This is achieved by insulating material and heating 
wires wrapped around the outer walls of the sample line tubing, and resistive heating tape 
and insulating material wrapped around the outer walls of the ring-down cavity. The 
temperatures of the sampling line and the cavity are monitored separately throughout the 
measurements. In our experimental measurement setup, the flow rate of the bacterial 
headspace sample is controlled with flow-controllers or a needle valves, and with closing 
valves of the bacterial container.  
 
Fig.10. Illustration of a custom built sampling line of a CRDS instrument. Green arrows 
indicate a flow towards the ring-down cavity, and red arrows a flow away from the cavity.  
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The bacterial containers used in our measurement setup are also custom made, and described 
in Figure 11a and 11b. Our setup is suitable for both one-point and continuous 
measurements, discussed above. Our system is not automated, meaning that the valves have 
to be adjusted manually – opened by hand at the beginning of a measurement, and closed 
after it is concluded – however, in other experimental systems automated valves have also 
been used successfully.103,104 Our sampling line and the ring-down cell are pumped by a 
mechanical vacuum pump, and a pressure gauge is used for monitoring the pressure inside 
the cavity, and consequently, the pressure of the sample. The places of the flow-controllers, 
needle valves and pump in our sampling systems can be found from Figures 11a and 11b. 
 
Fig.11a. The sampling and measurement setup for HCN detection from the headspace of 
aerobic bacteria.5 
 
Fig.11b. The sampling and measurement setup for HCN detection from the headspace of 
anaerobic bacteria.5 
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The bacterial headspace sampling techniques in general can be on- or offline. Offline 
sampling techniques include different kinds of bags and containers, where the bacterial 
headspace sample can be introduced, for example, by sucking the gas into a syringe through 
a penetrable membrane,105 and emptying the content into a sampling bag or a container, or 
directly into the measurement instrument. Offline samples can also be taken directly from 
the culture container, by connecting the container to the instrument with a sampling line, like 
in our custom built setup illustrated in Figure 10. Online sampling, which is generally used 
with the continuous, real-time measurements, can also be achieved with a sampling line that 
connects the bacterial container directly to the analyzer. The measurement instrument 
ultimately determines, what kind of sampling should be used, and in this aspect CRDS is 
quite versatile.  
Bacterial cultures have certain requirements for the atmosphere they grow in, and the 
requirements depend on whether the bacterial species is aerobic or anaerobic. Aerobic 
bacteria require oxygen to survive, and anaerobic bacteria, on the contrary, can tolerate only 
small amounts of oxygen, or not at all. During a CRDS measurement, small portion of the 
headspace gas flows out of the bacterial container, and consequently, the same amount of 
gas mixture has to simultaneously flow in, so that the amount of headspace gas remains 
relatively constant. This inflowing gas mixture can be either regular air or anaerobic gas 
mixture – which in our experiments is 85% N2, 10% H2 and 5% CO2 – depending on the 
type of bacteria studied. Sometimes an additional catalyst has to be included in the bacterial 
container, in order to remove any remaining oxygen, as described in Figure 11b. Our 
experimental setup also includes an incubator for the bacterial containers, which can be 
adjusted to a desired culturing temperature. 
 
3.6.1.1 Sampling System for Aerobic Bacteria 
 
The experimental setup for aerobic bacteria is illustrated in Figure 11a. The bacterial culture 
is placed and incubated in a 300 mL airtight container, which has two valves, one of which 
is connected to ambient air, and the other to the sampling line described earlier in this 
chapter. Placed between the bacterial container and the CRDS instrument is a flow-
controller, which regulates the flow of the bacterial headspace air into the ring-down cavity. 
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Depending slightly on the produced level of HCN, the flow rates used are between 10 and 
50 mL/min.5 
 
 
3.6.1.2 Sampling System for Anaerobic Bacteria 
 
The experimental setup for anaerobic bacteria is illustrated in Figure 11b. The bacterial 
culture is placed and incubated in a 300 mL airtight container, which has two valves, one of 
which is connected to the anaerobic gas mixture (85% N2, 10% H2 and 5% CO2), and the 
other to the sampling line described earlier in this chapter. Placed between the container and 
the gas mixture is a pressure gauge, which monitors the pressure inside the container, and a 
flow-controller, which is used to regulate the flow of the gas mixture into the container. 
Placed between the bacterial container and the CRDS instrument is a needle valve, which is 
used for adjusting and stabilizing the gas pressure in the container, and also for regulating 
the flow of the headspace gas into the CRDS instrument. During the sampling, flow rate of 
10 mL/min flow is used.5 
 
  
3.6.2 Breath Sample Measurements 
 
The general features and advantages of breath analysis, as well as its applicability in clinical 
work, have been discussed in detail in the earlier chapters, however, one important aspect 
has only been briefly mentioned – sampling. Successful collection of exhaled breath is vital 
for the results of breath analysis measurement,106 however, it is still one of the aspects within 
this diagnostic technique that is most often performed unreliably. Breath analysis can be fast 
and easy, but there are many variables that can make the sampling challenging, for example, 
the heterogeneity of the breath gas mixture, and the variation in breath gas concentrations 
amongst individuals from different age, gender or ethnic group. The most common mistake 
with breath analysis is choosing the sampling method poorly considering the substance of 
interest, which usually leads to major errors in the end results of the measurements. 
The easiest and most common sampling technique is to collect both the dead-space and the 
alveolar air at the same time. A sample acquired this way is often referred to as “mixed 
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expired air”. With this technique the breath sample can be simply exhaled into a sampling 
bag, container or the measurement instrument, and no additional monitoring or restrictions 
are needed. However, the drawback of this technique is that the sample is diluted because of 
the dead-space air, which does not contain the substances transferred to alveoli from blood. 
In some cases, the dilution effect can be neglected, however, it can also have a major effect 
on the end results, especially when the substance of interest is present in the breath in very 
small concentrations. Other sampling techniques include collecting only the alveolar air, 
referred to as “alveolar sampling”, and collecting a sample of rebreathed air, where the same 
breath is repeatedly exhaled and inhaled multiple times, before the sample in collected. 
Collection of alveolar air is ideal for reliable breath gas analysis, however, it is not as 
effortless as collecting mixed expired air. First of all, the alveolar part of the exhalation has 
to be identified, in order to know, which part of the breath gas to collect. This can be achieved 
by monitoring a certain component or feature of the respiration, such as CO2 or temperature, 
and collecting the breath sample only when the monitored feature signals the end of the dead-
space air. Monitoring the respiration as a function of time can also be used to standardize 
the breath analysis measurement, and even out differences between individuals. The alveolar 
part of the exhaled breath can also be estimated and collected at the near end of an 
uninterrupted exhalation, however, this is not as reliable as monitoring the respiration. 
Rebreathed air usually represents fairly well the composition of alveolar air, being either 
identical or equivalent to it. Rebreathed air is also much easier to collect compared to 
alveolar air, because no monitoring of the respiration is needed. Some studies have suggested 
that the rebreathed air could be warmed during the repeated exhalation and inhalation, which 
would increase the temperature of the airways, and thus, maximize the transfer of water 
soluble substances from the fluid of the airways to the exhaled air.14 The same study claims 
that alveolar sampling is best suited for hydrophobic substances, which exchange in the 
alveoli, and rebreathed air for hydrophilic substances, which exchange also in the airways. 
Many studies have suggested that the use of CO2 as a normalizing factor could help 
standardize the breath sampling, decrease the variation between individuals and different 
breathing patterns, and monitor the quality of the respiration.107-109 Normalizing with CO2 
means that the measured CO2 concentration from the breath sample is normalized to 
correspond the generally accepted mean value (~4%), and consequently, the concentration 
of the substance of interest in the sample is also changed in the same proportion. 
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As mentioned in the previous section about the bacterial headspace measurements, the 
materials of the sample containers, bags or sampling lines have to be unreactive with the 
sample. The same features about the condensation of water, discussed previously, also apply 
to breath samples. The custom built sampling line illustrated in Figure 10 is also suitable for 
breath samples. With breath sampled, however, the sampling line is connected to a breath 
gas bag, container, or a mouthpiece, not a bacterial container as in Figure 10, and a flow-
controller or a needle valve is placed in between so that the flow of the sample into the 
measurements instrument can be controlled. Breath sampling can be offline or online – 
collecting the samples in bags, containers or sorbents, or introducing the sample straight to 
the measurement instrument, respectively. 9,107 The disadvantage of offline sampling is the 
loss of sample components to diffusion through the container walls and adsorption to them, 
or dissolution of sample components to the condensed moisture on the container walls.110 
Breath samples always contain moisture, because water is a major component of exhaled air, 
and it is practically impossible to prevent condensation in the sample containers or sampling 
line completely. Condensation can be minimized by heating the sample containers or 
sampling line. However, the heating has to be continuous from sampling to analysis, which 
can be difficult to achieve in practice with offline sampling, especially if the sample bags or 
containers have to be transferred. Offline sampling is usually used only, when online 
sampling is impossible, for example, when sampling and analysis are carried out in different 
places, such as at the home of the patient and in hospital, and samples have to be transferred 
from one place to another. When offline sampling is used, the sample that is collected is 
usually mixed expired air or rebreathed air, both discussed earlier, and what is measured 
with the analyzer is the one-point concentration of this exhalation. Online sampling allows 
the continuous measurement of breath, so that the real-time concentrations of multiple 
exhalations during a certain time period can be monitored. However, one-point 
measurements from one exhalation are also possible with online sampling. An example of a 
custom built mouthpiece16 for online breath sampling, is illustrated in Figure 12. Often with 
one-point measurements, the preferred protocol is to measure the concentrations from 
multiple different exhalations, and use the average value as the end result.107 With offline 
sampling this requires the collection of multiple breath samples to separate containers. 
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Fig.12. Mouthpiece for measurements of mouth exhaled air.16 In the small picture, the 
mouthpiece and the connective tubing are covered with insulating material. 
  
Another aspect that should be taken into account with breath sampling, is that the 
concentrations measured from mouth exhaled breath may be vastly different from those 
measured from nose exhaled breath.9,16,47-49 In most cases, as with ammonia, HCN and sulfur 
containing compounds, the reason for this is the bacterial flora of the oral cavity, which has 
been discussed previously in this thesis. The effects of bacterial activity on the breath sample 
concentrations should be evaluated separately for each biomarker, and if possible, minimized 
with an appropriate method, such as cleansing the oral cavity with a mouthwash, or 
otherwise keeping the oral cavity in constant conditions.43,111 However, in some cases 
bacterial activity has such a major impact on the analysis that only nose exhaled air can be 
considered as a reliable source for breath samples. In comparison to sampling apparatus for 
mouth exhaled air in Figure 12, an example of a nosepiece40 suitable for the collection of 
nose exhaled air is illustrated in Figure 13. These sort of mouth- and nosepieces can be used 
for both offline and online sampling – they can be connected either to a sampling bag or a 
container, or straight to the sampling line, such as that in Figure 10.  
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Fig.13. Nosepiece for measurements of nose exhaled air.40 The nosepiece and the connective 
tubing are covered with insulating material, and the nosepiece is securely attached to the 
individual’s head. 
 
In addition to differences between nose and mouth exhaled concentrations, the background 
level of the substance of interest in the ambient air should also be considered before each 
measurement. As mentioned earlier in this thesis, it is important to distinguish between 
exogenous and endogenous concentrations, in order to know, which part comes from the 
body and which from the outside.9,107,109 One method to account for the effect of ambient air 
concentrations on the human exhaled air is to monitor the ambient air before sampling, and 
record, whether the values stay below a limit that can be considered negligible compared to 
the endogenous levels. Another method is to breathe clean air for a few minutes before the 
measurement, so that the lungs and airways are clear of contaminants. This so called “lung 
wash” does not, however, reliably clean the whole body from exogenous concentrations, and 
it can also be time consuming, which is disadvantageous considering routine patient work.  
Other aspects that should be considered with reliable breath gas sampling are, firstly, to 
ensure that the subject giving the sample is breathing with regular speed and volume, and 
has a firm contact on the mouth- or nosepiece through which the sample is exhaled, and 
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secondly, that the subject is relaxed and keeping a good posture. These seemingly minor 
features can have a critical effect on the breath measurement.109 Holding one’s breath even 
slightly can increase the observed concentrations significantly, and therefore, should also be 
avoided. It has been suggested in earlier research that in order to minimize the differences 
between breathing patterns of different individuals, a timer or a metronome could be used to 
control the pace of the respiration. As the main complication with breath analysis is the lack 
of standardization, mostly regarding sampling, the use of pacers seems advisable.  
As correct sampling is crucial for reliable and reproducible breath analysis, finding solutions 
for its standardization in the future is extremely important. Several studies have been carried 
out to evaluate the differences between sampling techniques, and to discuss their advantages 
and limitations, but consensus has not been reached about the common guidelines that should 
be followed throughout this field of research. Breath analysis could be one of the next 
generation diagnostic tools, however, its permanent integration to clinical work is impossible 
before the method is reliable. Therefore, a large portion of the future research should be 
aimed at the standardization of breath analysis, especially sampling, which seems to be 
lacking considerably compared to, for example, the sensitivity of different analysis 
instruments. 
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4. Experimental Demonstration: Detection of Hydrogen 
Cyanide from P. aeruginosa and Oral Anaerobes 
 
The previous studies of our group suggest that the mean level of HCN in mouth exhaled 
human breath from healthy subjects is around 4.0 ppb,40 with concentrations ranging from 
1.2 to 14.3 ppb. These levels exceed the HCN concentrations in the ambient air of our 
laboratory (≤0.3 ppb), and are surprisingly high for healthy subjects. This lead us to question, 
whether all the HCN detected from exhaled breath actually comes from the lungs, or whether 
it could also originate from somewhere else, for example, the airways or the oral cavity. The 
bacterial flora of the oral cavity is extremely diverse, and therefore, we decided to investigate 
if any of these oral bacteria are able to produce HCN, and if so, could the produced levels 
affect the concentrations detected from human exhaled breath. 
We used P. aeruginosa in our study as a positive control, because its HCN production has 
already been established and investigated thoroughly in previous studies. We also used it to 
evaluate and test our analysis method, setup and sampling. As a negative control, we used 
Escherichia coli. A large number of common oral bacteria were screened for HCN 
production. Those included in the later parts of this study – the CRDS measurements – are 
some of the most potent oral pathogens. This chapter describes the screening method we 
used for the HCN production of oral bacteria, as well as the results and conclusions of the 
screening. The CRDS measurements and their results are discussed in detail, including 
concluding remarks and prospects for future research. The applicability of our custom built 
sampling line considering the bacterial headspace measurements is also evaluated in the 
following sections. 
 
4.1 Preliminary Screening Method 
 
Before the headspace measurements with CRDS, it was necessary to do a screening of the 
oral bacteria, in order to exclude those species that produce no HCN, or minimal amount of 
it. Those bacteria giving positive results, and therefore, capable of producing HCN in 
sufficient amounts, were considered for further studies with CRDS measurements. The 
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bacteria chosen for the screening were the most prominent species of the oral cavity, and 
they are listed in Table 3. 
 
Table 3. The reference strains of bacterial species included in the preliminary screening. 
Positive results are referred to as strong (+++), moderate (++) or minor (+). 
Bacterial species Strain HCN 
Aggregatibacter actinomycetemcomitans ATCC29253 (a) neg 
Aggregatibacter actinomycetemcomitans ATCC 43718 (b) neg 
Aggregatibacter actinomycetemcomitans ATCC 33384 (c) neg 
Aggregatibacter actinomycetemcomitans IDH 781 (d) neg 
Aggregatibacter actinomycetemcomitans IDH 1705 (e) neg 
Aggregatibacter actinomycetemcomitans C 59 A (x) neg 
Campylobacter rectus ATCC33238 neg 
Candida albicans ATCC 19915 neg 
Escherichia coli ATCC 25922 neg 
Fusobacterium nucleatum sp. nucleatum ATCC 25586 neg 
Fusobacterium nucleatum sp. polymorphum ATCC 10953, CCUG 9126T neg 
Fusobacterium nucleatum sp. vincentii ATCC 49256, CCUG 37843T neg 
Fusobacterium periodonticum ATCC 33693 + 
Haemophilus influenzae ATCC 49766 neg 
Lactobacillus rhamnosus GG ATCC 53103 neg 
Moraxella sp. FD P 5 (clinical) neg 
Porphyromonas asaccharolytica ATCC 25260 N/A 
Porphyromonas endodontalis ATCC 35406 +++ 
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Table 3. (continued) The reference strains of bacterial species included in the preliminary 
screening. Positive results are referred to as strong (+++), moderate (++) or minor (+). 
Bacterial species Strain HCN 
Porphyromonas gingivalis ATCC 33277 (a) +++ 
Porphyromonas gingivalis W50 (b) +++ 
Porphyromonas gingivalis OMG 434 (c) neg 
Porphyromonas salivosa NCTC 11632 +++ 
Prevotella intermedia ATCC 25611 + 
Prevotella nigrescens ATCC 35563 +++ 
Staphylococcus aureus ATCC 25923 neg 
Streptococcus mutans ATCC 27351 neg 
Tannerella forsythia ATCC 43037 neg 
 
The preliminary screening gave seven positive results, of which four were from the 
Porphyromonas genus, two from the Prevotella genus and one from the Fusobacterium 
genus. The bacteria giving positive results were included in the next part of the study – the 
CRDS measurements.  
In addition to the reference strains of different oral pathogens listed in Table 3, some clinical 
strains of P. gingivalis and Porphyromonas endodontalis were also screened for possible 
HCN production. One clinical strain (P. gingivalis 4753E) was ultimately chosen for the 
headspace measurements with CRDS, because it gave a strong positive result in the 
preliminary screening test. The screening method used was a picric acid HCN test, which is 
described in detail in the next section. 
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4.1.1 The Picric Acid Test 
 
Pure picric acid (2,4,6-trinitrophenol) solution has a bright yellow color, which changes to 
orange when in contact with free HCN. This color change is the result of a reduction reaction 
of picric acid to isopurpuric acid,112 when in contact with cyanide. The structure of picric 
acid is represented in Figure 14. 
 
Fig.14. Proposed chemical structure of picric acid.112 
 
In the HCN test, the color intensity of the reduction reaction depends on the amount of free 
HCN present, hence, very dark orange or red color is observed with high HCN 
concentrations, compared to the light orange of smaller concentrations. Different color 
changes are illustrated in Figure 15, ranging from pure picric acid solution on the left, to the 
very dark orange of strongly reacted picric acid on the right. 
 
 
 
 
 
Fig.15. Color changes of picric acid from bright yellow (no reaction), through light orange 
(minor reaction) and dark orange (moderate reaction), to red (strong reaction). 
 
In our screening test, 120 µL of 0.8% picric acid solution was pipetted into a cork of an 
Eppendorf tube, and three of the corks were placed on the top half of a bacterial culture plate. 
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The bottom half of the culture plate, with the culture media and bacteria, was placed on top 
of the top half, and sealed with tape. These culture plates were then carefully placed into an 
incubator, and during the culturing process picric acid changed color, if HCN was present, 
and remained yellow if not. Figure 16 illustrates the setup described above. 
 
Fig.16. Picric acid drop test setup within a culture plate. Culture media (red) and bacteria 
(brown) are on the top part of the culture plate, and picric acid corks on the bottom part. 
Culture plates were sealed with a tape, which gave the set up some support during the 
incubation. 
 
4.1.2 Limitations of the Test and Validity of the Results 
 
We chose the picric acid test for our preliminary screening, because it is a rapid and easy 
way for screening large numbers, such as the many oral bacteria we wanted to examine. 
However, the picric acid test has some major limitations, which can lead to unreliable results. 
First of all, the picric acid test as we used it is purely visual, and strongly dependent on the 
individual observing the color change. In our case, this was not an issue since we only needed 
rough estimations of color change stages from yellow to dark orange. In some cases, the 
color change should be more accurately measured, and for example, absorption 
measurements or a color analyzer could be used for this purpose. Secondly, both picric acid 
and isopurpuric acid are thermally unstable substances, so changes in temperature can affect 
the color change process.112 In our study this was again not a great issue, since only an 
approximate estimation of the color changes was sufficient. However, in other cases, the 
temperature effect should be taken into account, and temperature controlled in some way. 
Thirdly, it has been noted that picric acid reacts not only with HCN, but also with some 
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sulfur containing species. This was a major concern in our study, since anaerobic bacteria in 
general are known to produce many sulfur containing compounds, and some of them in large 
amounts. In our case, this could have led to false positive results in the screening test, and 
also render the quantitative aspect of the color change useless, since there was no way to 
separate the color change caused by HCN, and that caused by sulfur compounds.  However, 
the negative results were not affected by this limitations, since a negative result meant that 
no HCN or sulfur compounds were produced. Therefore, we could still reliably exclude 
many of the oral pathogens by the picric acid screening test, and continue the study with 
those giving positive results, whether true or false. 
Because of the limitations discussed above, we decided to use the picric acid test in our study 
only as a screening method for excluding those species giving a negative result. The 
connection of color change to HCN concentration would be reliable only with species that 
produced no sulfur containing compounds, and because we had no means to investigate this, 
the quantitative aspect of the color change was neglected. In conclusion, the picric acid test 
was a fairly easy way to screen for negative results in HCN production of anaerobic bacteria, 
but was not suitable in screening for positive results. In our case, it was also not suitable for 
quantitative analysis of any kind.        
      
4.2 Headspace Measurements with Cavity Ring-Down 
Spectroscopy in vitro 
 
The measurement setup, sampling and method used for the headspace measurements of 
bacterial cultures were described earlier in section 3.6.1. This section presents the CRDS 
measurement results from different bacterial species chosen, with the preliminary screening 
method introduced in the previous section, and discusses the meaning and relevance of the 
results. The results introduced and discussed in the following sections are also represented 
in our published paper.5  
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4.2.1 Positive and Negative Control 
 
P. aeruginosa and its relevance as a pathogen was introduced in section 2.2.1. As mentioned 
at the beginning of this chapter, P. aeruginosa was chosen for our study as a positive control, 
because its HCN production has been established and studied previously. It has been noted 
that P. aeruginosa is capable of producing significant amounts of HCN, and therefore, it was 
an appropriate species to test our measurement setup and protocol with. The aim of using a 
positive control was to show that our proposed measurement method and setup is valid for 
the determination of HCN from the headspace of bacterial cultures. The next sections 
introduce and discuss the main results of our headspace measurements from P. aeruginosa. 
In addition to P. aeruginosa as a positive control, we had E. coli as a negative control in our 
study. The purpose of using a negative control was to further validate and test our 
measurement method and setup. The results of HCN headspace measurements from the 
negative control are also discussed briefly in the next sections. 
 
4.2.1.1 Culturing Method 
 
The ATCC BAA47 reference strain of P. aeruginosa was used as a positive control, and the 
ATCC 25922 reference strain of E. coli as a negative control. Both reference strains were 
obtained from the American Type Culture Collection (ATCC).  
The bacterial strains were stored dormant in skim milk at –80 °C. Before analysis, small 
amount of the stored bacteria was streaked from the frozen skim milk to a 100 mm culture 
plate, with tryptic soy agar (TSA) as the nutrient, and incubated for 24 hours at 37 °C. After 
the activation, one single colony was chosen, streaked onto a new TSA culture plate, and 
placed in an airtight container used in the HCN headspace measurements and described in 
section 3.6.1.1. 
This culturing method was used for both P. aeruginosa and E. coli. For the offline 
measurement, triplicate and duplicate cultures were prepared for P. aeruginosa and E. coli, 
respectively, in order to detect the variation in HCN production between cultures growing 
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in our setup, in identical conditions. For the online measurement, one plate of P. aeruginosa 
was prepared. 
 
4.2.1.2 Results 
 
In the one-point measurement of P. aeruginosa, the culturing time was 12 hours, after which 
the HCN concentration was measured. Relatively high levels of HCN were detected from 
the headspace of all the triplicate cultures: 4602, 3877 and 5207 ppb, respectively.  
One continuous online measurement was also done. The resulting “dynamic profile” of HCN 
production during 60 hours of culturing is presented in Figure 17.  
 
 
Fig.17. Dynamic profile of HCN production by P. aeruginosa ATCC BAA47. The HCN 
concentration was measured every 20 minutes, but for clarity, the data points are shown here 
two hours apart.5  
It can be observed from this dynamic profile that the concentration of HCN stayed low for 
the first 4 to 5 hours of culturing, but increased dramatically after that until reaching the 
maximum concentration of 8900 ppb at around 18 hours. It can also be observed that there 
was a period between 16 to 20 hours of culturing, where the HCN concentration remained 
65 
 
 
relatively steady for several hours.  After this period, the concentration started to decrease 
steadily until the end of the measurement. It can be estimated that the concentration would 
have continued decreasing until zero, if the measurement was continued further. 
The HCN concentrations from the headspaces of the duplicate cultures of E. coli reference 
strain were measured after 24 hours of culturing, but no HCN was detected. This was an 
expected result, since E. coli was our negative control, and as such, was not expected to 
produce HCN. 
 
4.2.1.3 Discussion 
 
Measurements done for P. aeruginosa with our experimental setup and protocol were 
successful, and the results consistent with previous results.113,114 The strain used in our 
measurements grew well under the conditions of our setup, and produced significant 
amounts of HCN during both the one-point and the continuous measurements. Triplicate 
cultures were incubated simultaneously in the same conditions, and similar results were 
achieved from each of them. Slight differences in the concentrations measured are most 
likely due to differences in the successfulness of the growth between the different cultures. 
Consequently, the culture that grew most successfully produced higher concentrations of 
HCN, compared to the other two. 
When comparing the dynamic profile measured for P. aeruginosa with the general bacterial 
growth curve in Figure 18, the similarities observed between them are obvious. As in the 
dynamic profile, there is also a steady-state at the beginning of the growth curve, where the 
number of bacteria remains low and relatively constant. After this so called “lag phase”, the 
number of bacteria starts to increase rapidly, as did the HCN concentration in the dynamic 
profile. This is the phase were the bacteria actively grow and reproduce, effectively using all 
the nutrients available in the culturing media. If the nutrients were limitless, the active 
growth could theoretically continue forever, but since this is rarely the case, the active 
growth stops, when there are no more available nutrients. The bacteria already existing 
continue to live on for a period of time, but they no longer reproduce effectively, and 
therefore the amount of active bacteria stays stationary. This stationary phase was also 
observed in the dynamic profile of the HCN production by P. aeruginosa. Ultimately, the 
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bacteria start to die, since there are no longer any nutrients for them to survive on, and the 
number of viable bacteria starts to steadily decrease, as did the HCN concentration in the 
dynamic profile. These similarities between the bacterial growth curve and the dynamic 
profile of HCN production suggest that HCN might be an important metabolic product of P. 
aeruginosa, since it is released steadily throughout the growth of the bacteria. These 
similarities also further validate that our method for culturing the bacteria, and measuring 
the HCN produced, is successful.        
Fig.18. Ideal bacterial growth profile, representing the relative change in the amount of 
bacteria as a function of time (arbitrary units). The dashed line after exponential phase 
indicated the theoretical growth of the bacteria, if the amount of available nutrients was 
limitless.  
Results from E. coli suggest that there is no additional HCN produced, for example, by the 
TSA or culture plates. This validates that our suggested setup is reliable in the measurement 
of headspace samples from bacterial cultures, and gives correct negative and positive results.    
 
4.2.2 Oral Anaerobes 
 
Some of the oral anaerobes and their relevance as pathogens were introduced in section 2.2.1. 
The next sections describe and discuss thoroughly the main results of our CRDS headspace 
measurements for selected oral anaerobes, with special emphasis on P. gingivalis. 
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Based on the preliminary screening, with the picric acid drop test discussed earlier in this 
chapter, seven strains of oral anaerobes were chosen for the CRDS screening test. These 
seven strains include those, which gave a positive result in the picric acid preliminary 
screening: F. periodonticum ATCC 33693, P. endodontalis ATCC 35406, P. gingivalis 
ATCC 33277, P. intermedia ATCC 25611 and P. nigrescens ATCC 35563. P. salivosa 
NCTC 11632, which gave a strong positive result in the preliminary screening, was not 
included in the CRDS screening, because the strain was unavailable for us at the time. We 
also decided to choose only one of the two P. gingivalis strains, which gave a positive result 
in preliminary screening, for our CRSD screening. In addition, we also wanted test two 
strains, which gave negative results in the preliminary screening: F. nucleatum sp. 
nucleatum ATCC 25586 and T. forsythia ATCC 43037. We decided to include these strains, 
because of their major roles as oral pathogens, and because of the possible unreliability of 
the picric acid screening test. 
We also conducted both one-point and dynamic CRDS measurements of HCN for four 
different strains of P. gingivalis, in order to investigate its HCN production capability even 
further. 
 
4.2.2.1 Culturing Method 
 
With the exception of P. gingivalis OMG 434, which was from the Gothenburg Culture 
Collection, all other reference strains were obtained from ATCC. The clinical isolate P. 
gingivalis 4753E was obtained from a patient with periodontal disease. All the strains were 
stored at −80 °C in frozen skim milk. Strains were activated by streaking onto Brucella blood 
agar (BBLTM, 211086) plates, supplemented with horse blood (5% v/v), hemin (5 mg/L) 
and vitamin K1, except T. forsythia ATCC 43037, which was cultured on TSA, with n-
acetylmuramic acid, and supplemented with sheep blood. All bacterial strains were 
incubated in anaerobic gas mixture (5% CO2, 10% H2 and 85% N2) at 37 °C for 72 hours. 
After the incubation, 5.0 mL of phosphate-buffered saline (PBS) was pipetted onto the 
Brucella blood agar plate, bacteria were gently scraped from the agar, and transferred into a 
FalconTM tube. This bacterial suspension was homogenized by vortexing for 30 seconds. 
From this 5.0 mL of bacterial suspension, 0.1 mL was pipetted onto a new Brucella blood 
agar plate, and this plate was placed in an airtight container for the HCN headspace 
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measurement. For CRDS screening tests, one plate was prepared for each strain of oral 
anaerobe. For offline measurements, duplicate plates were prepared for each P. gingivalis 
strain, and for online measurements, one plate was prepared for each P. gingivalis strain.  
After the HCN headspace measurement with CRDS was completed, pour plate method was 
used to determine the colony-forming unit (CFU) of P. gingivalis on the agar plates, and this 
was further used to estimate the growth conditions. P. gingivalis strains had CFUs in the 
range of (0.71–3.9) ×1010, and were considered to have grown successfully. 
 
4.2.2.2 Screening 
 
Five of the bacterial strains, chosen for the CRDS screening, produced detectable amounts 
of HCN during the 72 hours of culturing. All bacterial strains screened, as well as the 
concentrations of HCN produced, are listed in Table 4. The capability of anaerobic oral 
bacteria to produce HCN has been unknown previous to this study, and therefore, the results 
of HCN production by the screened oral anaerobes are a novel discovery. 
Table 4. HCN concentrations produced by oral pathogens measured with CRDS. 
* The measured HCN concentration was lower than 0.5 ppb, and therefore, below the 
detection limit of the CRDS instrument. 
Oral anaerobes HCN (ppb) 
24 h 48 h 72 h 
P. gingivalis ATCC 33277 5.5 10.9 8.4 
P. endodontalis ATCC 35406 1.6 1.8 1.5 
P. nigrescens ATCC 35563 <0.5* <0.5* <0.5* 
P. intermedia ATCC 25611 3.9 4.0 3.6 
F. nucleatum sp. nucleatum ATCC 25586 <0.5* 1.4 1.5 
F. periodonticum ATCC 33693 0.9 1.8 1.7 
T. forsythia ATCC 43037 <0.5* <0.5* <0.5* 
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As a result of this screening, we decided to choose P. gingivalis for the next part of our 
research, since it produced the highest levels of HCN out of all the oral anaerobes screened. 
The next part of the study consisted of offline and online measurements of four different 
strains of P. gingivalis with CRDS, and the aim was to further investigate the HCN 
production capability of this particular oral pathogen and its different strains.  
 
4.2.2.3 Offline Measurements of P. gingivalis 
 
Three different P. gingivalis strains were chosen for the offline CRDS measurements of 
HCN, described earlier in this thesis. The strains chosen included three reference strains 
(ATCC 33277, W50 and OMG 434) and one clinical strain (4753E) of P. gingivalis, some 
of which gave strong positive results in the preliminary screening with picric acid. The 
reference strains of P. gingivalis represent three different serotypes of this bacteria – A, B 
and C. The culturing method for these four strains was described earlier.  
The offline measurements were carried out by taking a sample from the headspace of the 
bacterial cultures, and measuring the HCN content at 24, 48 and 72 hours. In addition, the 
CO2 emitted by the P. gingivalis strains were also measured in order to monitor, whether all 
the strains were alive, and growing successfully. CO2 is a known product of several of the 
major metabolic routes of P. gingivalis, and thus provides an indicator for the state and 
vitality of the bacterial cultures. It was also necessary to investigate, whether a blank 
Brucella agar plate produced any HCN, because this would have interfered with the HCN 
measurements from the bacteria. Consequently, HCN and CO2 concentrations were also 
measured from the headspace of the blank Brucella agar plates at 24, 48 and 72 hours. The 
results were used as a background for the bacterial measurements. For each measurement, 
duplicates of the bacterial cultures and the agar plates were provided, in order to evaluate 
the consistency of the measurements. 
Results of the offline measurements are presented in Figure 19. For blank Brucella agar no 
HCN production was detected, or the HCN level produced was lower than the instrumental 
detection limit of 0.3 ppb. Even, if the blank plates produced some HCN, concentrations 
below the detection limit are so small that they do not interfere with the bacterial 
measurements. CO2 concentrations from the headspace of blank Brucella agar were also 
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measured, but no significant increase was detected at any point. The consistent CO2 
concentration of about 4% originated from the gas mixture (5% CO2, 10% H2 and 85% N2) 
used in the culturing of anaerobic bacteria, and as a carrier gas in the measurements. 
 
 
Fig.19. Detection of HCN and CO2 from P. gingivalis and blank Brucella agar.  P. gingivalis 
strains used were three reference strains (a) ATCC 33277, (b) W50, and (c) OMG 434, and 
one clinical isolate (d) 4753E. HCN from blank Brucella agar (e) served as a background. 
There were duplicate samples for each strain. Measurements were taken at 24, 48 and 72 
hours.5 
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Out of the four P. gingivalis strains, the reference strains ATCC 33277 and W50, and the 
clinical strain 4753E produced similar amount of HCN during the 72 hours of culturing: P. 
gingivalis ATCC 33277 produced 5.5–10.9 ppb, P. gingivalis W50 6.0–8.3 ppb and P. 
gingivalis 4753E 5.8–10.7 ppb. The highest levels were generally detected at 48 hours of 
culturing. The HCN levels detected from the third reference strain P. gingivalis OMG 434 
were significantly lower than those from the others, around 0.9–2.7 ppb. The CO2 levels in 
the headspace of all P. gingivalis strains were higher than that of the blank agar, which 
indicates that all the strains were actively growing. 
A strong correlation was found between the HCN production of each duplicate, during each 
time-point of the culturing, as seen in Figure 20, which indicates that the measurements and 
growing conditions were consistent. These results imply that the bacterial headspace 
measurements done with our measurement setup are reliable, as well as reproducible. The 
Spearman’s rank correlation test was applied to determine the statistical dependence of two 
variables, in this case, the HCN production of duplicate plates. In essence, the Spearman’s 
correlation between two variables is high, when the separate observations of these variables 
have a similar rank, and low when the observations have a dissimilar rank. The Spearman’s 
rank correlation coefficient (rs) tends towards ±1, the closer the variables become to being 
perfect monotone functions of each other. The significance of the correlation was evaluated 
with the p-value, which defines the probability of obtaining a result equal to, or greater than, 
what was actually observed, when the null hypothesis is true. Null hypothesis, on the other 
hand, states that there is no relationship between the two measured variables. Magnitude of 
the p-value determines, whether the null hypothesis is true or false for a set of observed 
values, and if it is false, the correlation is said to be significant. A significance level dictates 
a threshold for the p-value, below which the null hypothesis is rejected, and above which it 
is approved. The significance level can vary, and the characteristics of the study and its aim 
should be considered, when choosing the level, in order to obtain reliable results. The danger 
with the significance level is that choosing too large value can lead to detection of correlation 
that does not exist, whereas too small value can result in failing to detect a correlation that 
does exists. Typical values for the significance level are 0.05, 0.01 and 0.001. In our study, 
we used the significance level of 0.001, in order to detect only correlations that absolutely 
exist. 
In addition, a strong correlation was also found between HCN and CO2 concentrations of at 
least the two P. gingivalis strains that were most active in HCN production – the ATCC 
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33277 and W50 strains. This correlation can be observed in Figure 21. As mentioned earlier, 
CO2 is a common product of several important metabolic reactions, and therefore, an 
indicator of metabolic activity. Consequently, the strong correlation of HCN and CO2 
production implies that there could be a connection between these metabolites, and that HCN 
could possibly be an important side product of active bacterial growth as well.   
 
Fig.20. Spearman’s correlation profile for HCN produced by duplicate plates. The p-value 
is below the significance limit (<0.001), suggesting that the large positive correlation 
(rs=0.96) between the variables exists, and is significant. The HCN produced by all four 
strains was measured after 24, 48, and 72 hours, hence, the total of 12 data points.5 
 
Fig.21. Spearman’s correlation profile for HCN and CO2 produced by P. gingivalis ATCC 
33277 and W50. The p-value is below the significance limit (<0.001), suggesting that the 
large positive correlation (rs=0.89) between the variables exists, and is significant. The 
HCN and CO2 produced by the duplicate plates of the two strains were measured after 24, 
48, and 72 hours, hence, the total of 12 data points.5  
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4.2.2.4 Online Measurements of P. gingivalis 
 
As can be seen from the dynamic profiles of the three P. gingivalis reference strains and one 
clinical strain in Figure 22, the profiles of HCN production were quite different from the 
production profile of P. aeruginosa in Figure 17. 
 
Fig.22. Dynamic profiles of HCN production by four different P. gingivalis strains. 
Measurements were taken every 20 minutes, but data points only every two hours are shown 
here.5 
P. aeruginosa produced a smooth production profile, which was consistent with the growth 
profile in Figure 18, but the different P. gingivalis strains produced profiles distinct from 
each other, P. aeruginosa and the growth curve. Of course, one noticeable difference is that 
the concentrations produced during the online measurement of P. gingivalis were 
significantly lower than those of P. aeruginosa, which was expected due to the results from 
the previous one-point measurements. Lower concentrations most likely effect the 
production profiles, which might be one of reasons for the differences compared to P. 
aeruginosa. On the other hand, P. gingivalis ATCC 33277 and OMG 434 have clear phases 
in their HCN production, which increase steadily before reaching a maximum at 8.0 and 2.5 
ppb, respectively, before starting to decrease slowly during the latter part of the 
measurement. Both of these strain also seem to reach their peak HCN production after about 
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20 hours of culturing, which was also the case for P. aeruginosa in Figure 17. These profiles 
also seem somewhat consistent with the bacterial growth curve, which further support the 
possible connection between HCN production and metabolic activity. 
With P. gingivalis W50 and 4753E, the HCN concentrations increased more slowly before 
reaching their maximum values of 4.5 and 5.00 ppb, respectively. For W50 there was no 
notable decrease in the HCN production after the maximum value, and the concentration 
remained relatively stable until the end of the measurement. Decrease in the HCN production 
of 4753E clinical strain was not as prominent as with ATCC 33277 and OMG 434. However, 
there was a notable downward trend in its profile, which was most likely continued after the 
measurement ended. These profiles are quite different from the growth curve in Figure 18, 
as well as the production profiles of P. gingivalis W50 and 4753E, and P. aeruginosa. The 
reason for this difference remains unclear, and requires further knowledge about the features 
of the different bacterial stains, as well as different bacterial species. The HCN production 
mechanism should also be investigated more thoroughly in the future.  
 
4.3 Conclusions of the Experimental Demonstration 
 
Our study demonstrates that the proposed system – our custom build sampling line and 
CRDS instrument – can be applied in the screening and evaluation of HCN production by 
both aerobic and anaerobic bacteria. Measurements done for the positive control, P. 
aeruginosa, produced similar results compared to those observed in previous studies,113,114 
suggesting that the measurement setup was appropriate and the results reliable. In addition, 
results from both the one-point and the continuous, real-time measurements were consistent 
with each other, further indicating that both techniques are valid. However, we did observe 
that the real-time concentrations were slightly lower than those of the one-point 
measurements, which could be caused by two things. Firstly, the bacterial containers were 
flushed, with a continuous gas flow of 10 mL/min throughout the measurements, which 
probably had a diluting effect on the HCN concentration observed. Secondly, during the one-
point measurements both valves of the bacterial container were shut, except for the brief 
moment when the sample was taken, and consequently, the HCN produced accumulated in 
the sealed container. 
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We were able to prove that certain oral anaerobes, from Porphyromonas, Prevotella and 
Fusobacterium genera, can produce detectable levels of HCN in vitro, which is a novel 
finding. As HCN is a proposed biomarker for other bacterial infections, now that the 
connection to oral anaerobes has been established, it could be possible to consider HCN as 
a biomarker for the oral anaerobes as well. We also observed a strong correlation between 
the HCN and CO2 productions of P. gingivalis, which indicates a connection between 
bacterial metabolic activity and HCN production. According to these findings, HCN could 
be a side product of a major metabolic pathway, which however is absent or is drastically 
different, with many other oral anaerobes unable to produce HCN. The cyanogenesis of the 
oral anaerobes is still mostly unknown, and should be studied in the future in order to unravel 
why these certain bacterial species are able to produce HCN, when others are not. Results 
considering P. aeruginosa could provide a starting point for these future investigations, as 
its cyanogenic activity is more well-known. It would be extremely important to know, 
whether HCN produced by these bacteria is a side product with no specific function, or 
whether it is something more significant, and included in the bacterial genome for a reason. 
It has been suggested that HCN is a potent virulence factor,115 and as such, could increase 
tissue damage in the host species.31 As periodontal diseases often include the damage of both 
bone and soft tissue, it would be interesting to know, whether there is a connection between 
these diseases and the cyanogenesis of oral anaerobes, and consequently, what that would 
mean considering the biomarker aspect of HCN. Further investigations are also needed to 
clarify the underlying biological mechanisms that regulate the HCN biosynthesis in oral 
anaerobes, and searching for the HCN synthase encoding gene cluster (hcnABC) from their 
genome could be a recommended starting point. It has already been established that many 
oral bacteria are dependent on the presence of certain other bacterial species,116 and 
consequently, their functions are altered and enhanced in an environment with co-operating 
bacteria present.116-118 Therefore, it is also an interesting prospect for future research to study 
the HCN production of oral anaerobes in mixed bacterial flora. 
It was not possible to determine the real-time growth curve for the bacteria during our 
measurements, and therefore, there is no explicit way to compare the bacterial growth and 
HCN production. However, the dynamic profiles of the HCN production by P. gingivalis 
show similarities with the ideal bacterial growth profile, and this indicates that HCN 
production also correlates with the relative amount of bacteria, and is produced most 
prominently during the active growth phase of the bacteria. Considering future studies, it 
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would be interesting, if the bacterial growth profile and HCN production profile could both 
be monitored simultaneously, in order to further evaluate their connection. 
The purpose of this study was to establish a measurement setup for the HCN headspace 
measurements from both aerobic and anaerobic bacteria, and also to investigate, whether 
oral bacteria are able to produce detectable amounts of HCN in vitro. Both of these goals 
were reached, and the results were positive. However, even though this study proves that the 
oral anaerobes produce HCN in vitro, further research is necessary to determine, whether 
HCN is also produced in significant amounts in vivo. This requires mouth-exhaled breath 
analysis from individuals, with cyanogenic bacteria colonizing the oral cavity. If a 
connection between the cyanogenic oral bacteria and mouth-exhaled HCN is found, the 
possibility of HCN being a biomarker for periodontal diseases could be further considered. 
It would also confirm that the HCN measured from the exhaled breath does not originate 
entirely from the alveoli, but also from the oral cavity, which has been assumed to be true 
according to results from previous studies. This could further complicate the usage of HCN 
as a mouth exhaled breath biomarker for such conditions as cystic fibrosis, which relies on 
the fact that HCN is a specific biomarker for P. aeruginosa. 
 
5. Discussion and Conclusions 
 
The importance of biomarker research is undoubtedly clear to everyone. Biomarkers are one 
of the main, or in some cases only, means to identify diseases, monitor their progress and 
evaluate the success of the treatment. Volatile biomarkers can be analyzed from the human 
exhaled breath, which has many advantageous features compared to traditional sample 
media, such as blood or urine. For example, the volume of exhaled breath is practically 
limitless, whereas blood and urea can only be collected from one individual to a certain 
extent. Breath samples are also easier to take, and the method is noninvasive, which is 
desirable especially considering children and elderly patients. In addition, breath analysis is 
generally faster compared to traditional methods. Analysis of volatile biomarkers could, 
therefore, save significant amounts of time, and decrease the workload both in hospitals and 
laboratories, which would also ultimately decrease the cost of the treatment. The problem 
with breath analysis is the lack of standardization from sampling to concentration ranges, 
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and improving these aspects should be the main focus of future research, if breath analysis 
should be established as routine diagnostic tool. A few breath tests, such as the NO asthma 
test and the isotope labelled urea test for H. pylori infection, are already used routinely in 
clinical work. If similar reliable breath biomarkers can be found, they can undoubtedly reach 
the same diagnostic status. However, this requires more basic and applied research in the 
fields of chemistry, medicine, biology and engineering, and a desire to find alternative means 
to improve medical diagnostics, and knowledge of diseases and their treatment. Basic 
research, such as the one done for the experimental part of this thesis, creates the background 
for progress and new innovations, for example, in the medical field – a connection that 
should not be overlooked or dismissed.  
Small-molecule biomarkers are more easily identified than large VOCs, for example by LAS 
techniques, because of their simple spectrums with less overlapping of signals, or with 
sensors, which benefit from their simple structure and small size. Breath levels of acetone, 
methane, NH3, HCN, H2S and NO can already be detected down to ppt level, with high-
sensitivity techniques, such as CRDS, PAS, OFCS, PTR-MS and SIFT-MS, and to ppb level 
with TDLAS, MPS, IMS and various different sensors. Features, such as online sampling 
and continuous, real-time measurements are also possible, with nearly all of the 
aforementioned techniques. As sensitivity and other relevant features of the measurement 
instruments are no longer an issue, it is essential that other aspects of volatile, small-
molecule biomarker analysis also reach the same standard. Considering the development of 
next generation medical tools and treatments – which are increasingly sensitive, noninvasive, 
cheaper, faster, easier to use and manufacture, and accessible to everyone –  small-molecule 
biomarker analysis could be among the most promising ones.  
As mentioned earlier, many of the small-molecule biomarkers discussed in this thesis are 
connected to medical conditions that affect a major portion of the human population. The 
number of people with diabetes, for example, was 422 million in 2014, and has continued to 
increase since, because of the improving conditions in middle- and low income countries. It 
was estimated that 1.5 million deaths were directly caused by diabetes in 2012, and 
additional 2.2 million deaths were connected to high blood glucose.  Both kidney and liver 
diseases affect a large proportion of the whole adult population, and lead to millions of deaths 
per year worldwide. Periodontal diseases, on the other hand, affect 15-20% of the whole 
worldwide adult population, and are often underdiagnosed and left untreated. From these 
numbers alone, it is clear that the impact these few examples have on the health of the 
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humankind is enormous. Diagnostics, treatments, deaths, and additional related 
consequences of these diseases have a major effect, amongst other things, on the global 
economy. Therefore, it is extremely important to acknowledge the possibilities of the small-
molecule biomarkers related to these diseases, and how they could increase both the quality 
and availability of healthcare, and at the same time, decrease its cost.  
The results of the experimental part of this thesis were discussed thoroughly in the previous 
chapter, but it should be acknowledge here that these sort of basic studies are extremely 
important, when developing new analysis techniques and instruments for medical 
diagnostics. The basic features and mechanisms behind phenomena, such as biomarker 
metabolism and pulmonary gas exchange, are the driving forces by which such things as 
breath analysis work, and it is therefore, important to investigate them further. For example, 
when breath biomarkers for bacterial infections are studied, it should be intuitive to study 
the biomarker production by the bacteria both in vivo and in vitro, in order to unravel the 
meaning of the biomarker from the perspective of the producing species as well. In the field 
of volatile biomarker research, future challenges include trying to understand the underlying 
mechanisms for endogenous biomarker production, and their connection to exhaled breath. 
This, on the other hand, requires more research concerning both the human and microbial 
metabolisms, as well as the connections between biomarkers and diseases. It is also 
important to establish new biomarkers, and increase the portion of diseases that can be 
detected with them. Understanding the basics behind phenomena helps immensely, when 
trying to build a foundation for new innovations, and for this reason, it is vital that in the 
future, different areas of research aim to reinforce each other, and find comprehensive 
solutions for the demands of the modern world.        
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